<SEC-DOCUMENT>0001193125-24-274434.txt : 20241210
<SEC-HEADER>0001193125-24-274434.hdr.sgml : 20241210
<ACCEPTANCE-DATETIME>20241210172501
ACCESSION NUMBER:		0001193125-24-274434
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241210
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241210
DATE AS OF CHANGE:		20241210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SCANSOURCE, INC.
		CENTRAL INDEX KEY:			0000918965
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-COMPUTER & PERIPHERAL EQUIPMENT & SOFTWARE [5045]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				570965380
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26926
		FILM NUMBER:		241539464

	BUSINESS ADDRESS:	
		STREET 1:		6 LOGUE COURT
		CITY:			GREENVILLE
		STATE:			SC
		ZIP:			29615
		BUSINESS PHONE:		800.944.2432

	MAIL ADDRESS:	
		STREET 1:		6 LOGUE COURT
		CITY:			GREENVILLE
		STATE:			SC
		ZIP:			29615

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SCANSOURCE INC
		DATE OF NAME CHANGE:	19940214
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d900233d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:scsc="http://www.scansource.com/20241210" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-585">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-12-10_to_2024-12-10">0000918965</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="scsc-20241210.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-12-10_to_2024-12-10"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000918965</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-12-10</xbrli:startDate> <xbrli:endDate>2024-12-10</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-596">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-12-10_to_2024-12-10" format="ixt:datemonthdayyearen" id="ixv-597">December&#160;10, 2024</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-598">ScanSource, Inc.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-599">SC</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-600">00-26926</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-601">57-0965380</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-602">6 Logue Court</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-603">Greenville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-604">SC</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-605">29615</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-606">(864)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-607">288-2432</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-12-10_to_2024-12-10" format="ixt-sec:boolballotbox" id="ixv-608">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-12-10_to_2024-12-10" format="ixt-sec:boolballotbox" id="ixv-609">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-12-10_to_2024-12-10" format="ixt-sec:boolballotbox" id="ixv-610">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-12-10_to_2024-12-10" format="ixt-sec:boolballotbox" id="ixv-611">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-612">Common Stock, no par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-613">SCSC</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-12-10_to_2024-12-10" format="ixt-sec:exchnameen" id="ixv-614">NASDAQ Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-12-10_to_2024-12-10" format="ixt-sec:boolballotbox" id="ixv-615">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the annual meeting of the shareholders of ScanSource, Inc. (the &#8220;Company&#8221;) held on December&#160;10, 2024, (the &#8220;Annual Meeting&#8221;), the shareholders of the Company approved the ScanSource, Inc. 2024 Omnibus Incentive Compensation Plan (the &#8220;2024 Plan&#8221;). The 2024 Plan had previously been approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) and the Compensation Committee of the Board (the &#8220;Committee&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2024 Plan replaces the Company&#8217;s 2021 Omnibus Incentive Compensation Plan (the &#8220;2021 Plan&#8221;), and no further awards will be granted under the 2021 Plan. Awards outstanding under the 2021 Plan will continue in accordance with their terms. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2024 Plan permits the grant of any or all of the following types of awards to grantees: stock options, including <span style="white-space:nowrap">non-qualified</span> options and incentive stock options (&#8220;ISOs&#8221;); stock appreciation rights (&#8220;SARs&#8221;); restricted stock; deferred stock and restricted stock units; performance units and performance shares; dividend equivalents; and other stock-based awards. Eligible grantees include employees, officers, <span style="white-space:nowrap">non-employee</span> consultants and <span style="white-space:nowrap">non-employee</span> directors of the Company and its affiliates. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the 2024 Plan, the maximum number of shares of the Company&#8217;s common stock available for issuance upon settlement of awards shall be 2,234,543 shares of the Company&#8217;s common stock, plus that number of shares of the Company&#8217;s common stock subject to awards granted under the 2021 Plan which become available in accordance with the provisions below after the shareholders of the Company approve the 2024 Plan. However, the total number of shares of common stock that may be delivered pursuant to the exercise of ISOs granted under the 2024 Plan may not exceed 2,234,543 shares. The 2024 Plan imposes limitations on the amount of participant awards that can be granted in any single calendar year; requires most awards granted under the 2024 Plan to have a minimum vesting schedule of one year; prohibits the grant of discounted stock options or SARs or the repricing of options and SARs without shareholder approval; prohibits the payment of dividend equivalents unless and until the underlying award vests; and provides express requirements on what happens upon a change in control of the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee, or, where applicable, the Board or the Committee&#8217;s designee will administer the 2024 Plan and approve the grant and terms of awards (consistent with the terms of the 2024 Plan). All awards granted under the 2024 Plan are subject to the Company&#8217;s standard share retention guidelines and recoupment policies in effect from time to time. The Board reserves the right to amend the 2024 Plan, subject to shareholder approval where required by applicable law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing summary description of the 2024 Plan is qualified in its entirety by reference to the actual terms of the 2024 Plan, which are attached hereto as Exhibit 10.1 and incorporated herein by reference. For additional information regarding the 2024 Plan, please refer to &#8220;Proposal Number 4 &#8211; Approval of ScanSource, Inc. 2024 Omnibus Incentive Compensation Plan&#8221; on pages <span style="white-space:nowrap">24-32</span> of the Company&#8217;s definitive proxy statement, as filed with the Securities and Exchange Commission on October&#160;25, 2024. A Form of Restricted Stock Unit Award Certificate, which is filed as Exhibit 10.2 to this Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference, will be used to make grants of restricted stock units pursuant to the 2024 Plan. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.07.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company held its Annual Meeting on December&#160;10, 2024. The Company received proxies totaling 89.5% of its issued and outstanding shares of common stock, representing 21,501,384 shares of common stock, as of the record date. At the Annual Meeting, the shareholders voted on the following proposals, which are described in more detail in the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission on October&#160;25, 2024, and the results of the voting are presented below. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Election of Directors </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s shareholders approved the slate of directors consisting of eight members to hold office until the next annual meeting of shareholders or until their successors are duly elected and qualified, based on the following final voting results: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:65%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>

<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Nominee</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Against</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Abstain</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" colspan="2" align="center"><span style="font-weight:bold">Broker<br/><span style="white-space:nowrap">Non-Votes</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael L. Baur</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,377,276</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">424,253</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,432</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">692,423</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter C. Browning</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">18,275,242</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,531,939</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,780</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">692,423</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Frank E. Emory, Jr.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,083,727</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">717,799</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,436</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">692,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles A. Mathis</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">19,994,276</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">812,906</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,780</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">692,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vernon J. Nagel</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,070,876</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">730,170</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,916</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">692,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dorothy F. Ramoneda</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,086,925</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">711,942</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,094</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">692,423</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey R. Rodek</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,085,424</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">721,898</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,640</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">692,422</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Elizabeth O. Temple</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">20,011,309</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">796,006</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,646</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">692,423</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Advisory Vote to Approve the Compensation of the Company&#8217;s Named Executive Officers </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s shareholders approved, on an advisory basis, the compensation of the Company&#8217;s named executive officers, based on the following final voting results: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">20,277,859</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">492,152</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">38,952</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">692,421</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Ratification of Grant Thornton LLP as the Independent Auditors for Fiscal 2025 </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s shareholders ratified the appointment of Grant Thornton LLP as the Company&#8217;s independent auditors for fiscal 2025, based on the following final voting results: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:34%"/>

<td style="vertical-align:bottom"/>
<td style="width:32%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">21,290,044</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">209,384</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">1,956</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Approval of the ScanSource, Inc. 2024 Omnibus Incentive Compensation Plan </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s shareholders approved the 2024 Plan, based on the following final voting results: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">19,590,961</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">1,215,191</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">2,809</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">692,423</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Exhibit<br/>Number</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d900233dex101.htm">ScanSource, Inc. 2024 Omnibus Incentive Compensation Plan </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d900233dex102.htm">Form of Restricted Stock Unit Award Certificate (Service-Based) under the ScanSource Inc. 2024 Omnibus Incentive Compensation Plan </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">ScanSource, Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael L. Baur</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Date: December&#160;10, 2024</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Michael L. Baur</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d900233dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCANSOURCE, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2024
OMNIBUS INCENTIVE COMPENSATION PLAN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Effective Date, Objectives and Duration </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Adoption of the Plan</U>. The Board of Directors of ScanSource, Inc., a South Carolina corporation (the &#147;<U>Company</U>&#148;),
adopted the 2024 Omnibus Incentive Compensation Plan (the &#147;<U>Plan</U>&#148;) on October&nbsp;21, 2024 (the &#147;<U>Effective Date</U>&#148;), subject to approval by the stockholders of the Company within twelve (12)&nbsp;months after the
Board&#146;s adoption of the Plan. Awards, other than Restricted Shares, may be granted on and after the Effective Date; but, no such Awards may be exercised, vested, paid or otherwise settled, or any Shares issued with respect thereto, unless and
until the stockholders of the Company approve the Plan within the twelve (12)&nbsp;months after the Board&#146;s adoption of the Plan. Restricted Shares may only be granted if and after the stockholders of the Company approve the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Objective of the Plan</U>. The Plan is intended to attract and retain highly qualified persons to serve as employees, consultants and <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors and promote ownership by such employees, consultants and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of a greater proprietary interest in the Company, thereby aligning their
interests more closely with the interests of the Company&#146;s stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3 <U>Duration of the Plan</U>. The Plan commenced on the
date of adoption of the Plan by the Board, subject to approval by the stockholders of the Company within the twelve (12)&nbsp;months after the Board&#146;s adoption of the Plan. If the stockholders of the Company so approve the Plan, the Plan shall
remain in effect, subject to the right of the Board to amend or terminate the Plan at any time pursuant to Article 14 hereof, until the earlier of 11:59 p.m. (ET) on October&nbsp;21, 2034, or the date all Shares subject to the Plan shall have been
issued and the restrictions on all Restricted Shares granted under the Plan shall have lapsed, according to the Plan&#146;s provisions. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 2 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Definitions
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever used in the Plan, the following terms shall have the meanings set forth below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 &#147;<U>409A Award</U>&#148; has the meaning set forth in Section&nbsp;15.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 &#147;<U>5% Exception Limit</U>&#148; has the meaning set forth in Section&nbsp;5.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 &#147;<U>$100,000 Limit</U>&#148; has the meaning set forth in Section&nbsp;6.4(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 &#147;<U>Acquired Entity</U>&#148; has the meaning set forth in Section&nbsp;5.6(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 &#147;<U>Acquired Entity Awards</U>&#148; has the meaning set forth in Section&nbsp;5.6(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 &#147;<U>Affiliate</U>&#148; means any corporation, trade or business or other entity, including but not limited to partnerships, limited
liability companies and joint ventures, directly or indirectly controlling, controlled by or under common control with the Company, within the meaning of Section&nbsp;405 of the Securities Act. Affiliate includes any corporation, trade or business
or other entity that becomes such on or after the Effective Date. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 &#147;<U>Applicable Law</U>&#148; means U.S. federal, state and local laws applicable to
the Company, any legal or regulatory requirement relating to the Plan, Awards and/or Shares under applicable U.S. federal, state and local laws, the requirements of Nasdaq and any other stock exchange or automated quotation system upon which the
Shares are listed or quoted, the Code, and the applicable laws, rules, regulations and requirements of any other country or jurisdiction where Awards are or are to be granted, exercised, vested or settled, as such laws, rules, regulations and
requirements shall be in place from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 &#147;<U>Articles of Incorporation</U>&#148; means the Company&#146;s Amended and
Restated Articles of Incorporation, as amended and/or restated from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 &#147;<U>Award</U>&#148; means Options (including
Non-Qualified Options and Incentive Stock Options), SARs, Restricted Shares, Performance Units (which may be paid in cash), Performance Shares, Deferred Stock, Restricted Stock Units, Dividend Equivalents and Other Stock-Based Awards granted under
the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10 &#147;<U>Award Agreement</U>&#148; means a written agreement entered into by the Company and a Grantee setting forth the
terms and provisions applicable to an Award granted under this Plan, including any amendment or modification thereof. The Committee may provide for the use of electronic, internet or other <FONT STYLE="white-space:nowrap">non-paper</FONT> Award
Agreements and the use of electronic, internet or other <FONT STYLE="white-space:nowrap">non-paper</FONT> means for the acceptance thereof and actions thereunder by the Grantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11 &#147;<U>Beneficiary</U>&#148; means one or more persons or entities that become entitled to receive any amount payable under this Plan
after the Grantee&#146;s death. The Grantee&#146;s Beneficiary is the Grantee&#146;s surviving spouse, unless the Grantee designates one or more persons or entities to be the Grantee&#146;s Beneficiary. The Grantee may make, change or revoke a
Beneficiary designation at any time before his or her death without the consent of the Grantee&#146;s spouse or anyone the Grantee previously named as a Beneficiary, and the Grantee may designate primary and secondary Beneficiaries. A Beneficiary
designation must comply with procedures established by the Committee and must be received by the Committee before the Grantee&#146;s death. If the Grantee dies without a valid Beneficiary designation (as determined by the Committee), and the Grantee
has no surviving spouse, the Beneficiary shall be the Grantee&#146;s estate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.12 &#147;<U>Board</U>&#148; means the Board of Directors
of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.13 &#147;<U>Business Combination</U>&#148; has the meaning set forth in Section&nbsp;2.17(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.14 &#147;<U>Bylaws</U>&#148; means the Company&#146;s Amended and Restated Bylaws, as amended and/or restated from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.15 &#147;<U>Cause</U>&#148; shall have the same definition as under any employment or service agreement between the Company or any Affiliate
and the Grantee or, if no such employment or service agreement exists or if such employment or service agreement does not contain any such definition or words of similar import, &#147;Cause&#148; means, except as otherwise set forth in the Award
Agreement, (i)&nbsp;the Grantee&#146;s act or failure to act amounting to gross negligence or willful misconduct to the detriment of the Company or any Affiliate; (ii)&nbsp;the Grantee&#146;s dishonesty, fraud, theft or embezzlement of funds or
properties in the course of Grantee&#146;s employment; (iii)&nbsp;the Grantee&#146;s commission of, indictment for, or pleading guilty or confessing to any felony; (iv)&nbsp;the Grantee&#146;s gross neglect of, or prolonged absence from (other than
due to Disability and without the written consent of the Company or an Affiliate), Grantee&#146;s duties, (v)&nbsp;the Grantee&#146;s refusal to comply with any lawful directive or policy of the Company or any Affiliate, which refusal is not cured
by the Grantee within ten (10)&nbsp;days of such written notice from the Company or Affiliate, (vi)&nbsp;a material breach by the Grantee of any fiduciary duty owed to the Company or any Affiliate, (vii)&nbsp;the Grantee intentionally engaging in
any activity that is in conflict with or adverse to the reputation, business or other interests of the Company or any Affiliate or that is reasonably determined to be detrimental to the reputation, business or other interests of the Company or any
Affiliate, or (viii)&nbsp;the Grantee&#146;s breach of any restrictive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
covenant or other agreement with the Company or any Affiliate, including but not limited to, confidentiality covenants, covenants not to compete,
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants and <FONT STYLE="white-space:nowrap">non-disclosure</FONT> covenants. For purposes of the Plan, the Grantee&#146;s resignation without the Company&#146;s or an Affiliate&#146;s
written consent in anticipation of termination of employment for Cause shall constitute a termination of employment for Cause. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.16
&#147;<U>CEO</U>&#148; means the Chief Executive Officer of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.17 &#147;<U>Change in Control</U>&#148; shall be deemed to
have occurred upon the first occurrence of an event set forth in any one of the following paragraphs: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The accumulation
in any number of related or unrelated transactions (other than an offering of Shares to the general public through a registration statement filed with the Securities and Exchange Commission) by any Person of beneficial ownership (as such term is
used in Sections 13(d) and 14(d)(2) of the Exchange Act) of more than fifty percent (50%) of the combined voting power of the Company&#146;s voting stock; provided that, for purposes of this subsection (a), a Change in Control will not be deemed to
have occurred if the accumulation of more than fifty percent (50%) of the combined voting power of the Company&#146;s voting stock results from any acquisition of voting stock (i)&nbsp;by the Company or any Affiliate, (ii)&nbsp;by any employee
benefit plan (or related trust) sponsored or maintained by the Company or any Affiliate, (iii)&nbsp;by any Person that, prior to the transaction, directly or indirectly, controls, is controlled by, or is under common control with, the Company, or
(iv)&nbsp;by any Person pursuant to a merger, consolidation or reorganization involving the Company (a &#147;<U>Business Combination</U>&#148;) that would not cause a Change in Control under subsection (b)&nbsp;below; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Consummation of a Business Combination, unless, immediately following that Business Combination, (i)&nbsp;all or
substantially all of the Persons who were the beneficial owners of voting stock of the Company immediately prior to that Business Combination beneficially own, directly or indirectly, more than fifty percent (50%) of the combined voting power of the
Company&#146;s voting stock resulting from that Business Combination (including, without limitation, an entity that as a result of that transaction owns the Company or all or substantially all of the Company&#146;s assets, either directly or through
one or more subsidiaries) in substantially the same proportions relative to each other as their ownership, immediately prior to that Business Combination, of the voting stock of the Company and (ii)&nbsp;no Person has beneficial ownership of fifty
percent (50%) or more of the combined voting power of the Company&#146;s voting stock (including any entity that as the result of that transaction owns the Company or all or substantially all of, the Company&#146;s assets either directly or through
one or more subsidiaries); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) During any twelve (12)-month period, Incumbent Board Members cease to constitute a
majority of the Board; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) A sale or other disposition of all or substantially all of the assets of the Company, except
pursuant to a Business Combination that would not cause a Change in Control under subsection (b)&nbsp;above; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) A
complete liquidation or dissolution of the Company, except pursuant to a Business Combination that would not cause a Change in Control under subsection (b)&nbsp;above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, in the case of any Award that constitutes deferred compensation within the meaning of Section&nbsp;409A of the Code, there
shall not be a Change in Control unless there is a change in the ownership or effective control of the Company, or in a substantial portion of the assets of the Company, within the meaning of Section&nbsp;409A of the Code where necessary for such
Award to comply with Section&nbsp;409A of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.18 &#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended from time
to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.19 &#147;<U>Committee</U>&#148; has the meaning set forth in Section&nbsp;3.1(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.20 &#147;<U>Company</U>&#148; means ScanSource, Inc., a South Carolina corporation, and any successor thereto by operation of law or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.21 &#147;<U>Compensation Committee</U>&#148; means the compensation committee of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.22 &#147;<U>Corporate Transaction</U>&#148; has the meaning set forth in Section&nbsp;4.2(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.23 &#147;<U>Current Grant</U>&#148; has the meaning set forth in Section&nbsp;6.4(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.24 &#147;<U>Data</U>&#148; has the meaning set forth in Section&nbsp;18.22. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.25 &#147;<U>Deferred Stock</U>&#148; means a right, granted under Article 9, to receive Shares at the end of a specified deferral period.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.26 &#147;<U>Disability</U>&#148; or &#147;<U>Disabled</U>&#148; means, unless otherwise defined in an Award Agreement, or as otherwise
determined under procedures established by the Committee for purposes of the Plan: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as provided in (b)&nbsp;or
(c) below, disability or disabled means, for any Grantee, any injury, illness or sickness that qualifies as a long-term disability within the meaning of the Company&#146;s long-term disability program (&#147;<U>LTD Program</U>&#148;) and on account
of which such Grantee is entitled to receive LTD Program benefits; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the case of an Incentive Stock Option or an
Award granted in tandem with an Incentive Stock Option, disability and disabled has the meaning under Section&nbsp;22(e)(3) of the Code; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In the case of any Award that constitutes deferred compensation within the meaning of Section&nbsp;409A of the Code,
disability and disabled means as defined in regulations under Code Section&nbsp;409A where necessary for such Award to comply with Section&nbsp;409A of the Code. For purpose of Code Section&nbsp;409A, a Grantee will be considered to have incurred a
Disability or to be Disabled if: (i)&nbsp;the Grantee is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last
for a continuous period of not less than twelve (12)&nbsp;months, or (ii)&nbsp;the Grantee is, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous
period of not less than twelve (12)&nbsp;months, receiving income replacement benefits for a period of not less than three (3)&nbsp;months under an accident and health plan covering employees of the Grantee&#146;s employer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.27 &#147;<U>Disqualifying Disposition</U>&#148; has the meaning set forth in Section&nbsp;6.4(f). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.28 &#147;<U>Dividend Equivalent</U>&#148; means a right to receive cash or Shares equal to any dividends or distributions paid on Shares, if
and when paid or distributed, on a specified number of Shares, which dividends have a record date on or after the date of grant of the Dividend Equivalents or related Award and before the date Dividend Equivalents or related Award become payable.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.29 &#147;<U>Dodd-Frank</U>&#148; means the Dodd-Frank Wall Street Reform and Consumer
Protection Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.30 &#147;<U>DRO</U>&#148; has the meaning set forth in Section&nbsp;5.4(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.31 &#147;<U>Effective Date</U>&#148; has the meaning set forth in Section&nbsp;1.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.32 &#147;<U>Eligible Person</U>&#148; means any employee (including any officer) of, or <FONT STYLE="white-space:nowrap">non-employee</FONT>
consultant to, or <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director of, the Company or any Affiliate, or potential employee (including a potential officer) of, or potential <FONT STYLE="white-space:nowrap">non-employee</FONT> consultant
to, or potential <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director of, the Company or an Affiliate; provided, however, that (i)&nbsp;solely with respect to the grant of an Incentive Stock Option, an Eligible Person shall be any employee
(including any officer) of the Company or any Subsidiary Corporation and (ii)&nbsp;the Committee may establish additional eligibility criteria for determining an Eligible Person for any Awards granted hereunder. Solely for purposes of
Section&nbsp;5.6(b), current or former employees or <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors of, or <FONT STYLE="white-space:nowrap">non-employee</FONT> consultants to, an Acquired Entity who receive Substitute Awards in
substitution for Acquired Entity Awards shall be considered Eligible Persons under this Plan with respect to such Substitute Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.33
&#147;<U>ERISA</U>&#148; has the meaning set forth in Section&nbsp;5.4(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.34 &#147;<U>Exchange Act</U>&#148; means the Securities
Exchange Act of 1934, as amended, and all rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.35 &#147;<U>Exercise Price</U>&#148; means
(a)&nbsp;with respect to an Option, the price at which a Share may be purchased by a Grantee pursuant to such Option or (b)&nbsp;with respect to a SAR, the price established at the time a SAR is granted pursuant to Article 7, which is used to
determine the amount, if any, of the payment due to a Grantee upon exercise of the SAR. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.36 &#147;<U>Fair Market Value</U>&#148; means,
unless the Committee determines otherwise, a price that is based on the closing price of a Share reported on Nasdaq on the applicable date or on the established stock exchange which is the principal exchange upon which the Shares are traded on the
applicable date or, if the Shares are not traded on such date, the immediately preceding trading day. Unless the Committee determines otherwise, if the Shares are traded over the counter at the time a determination of Fair Market Value is required
to be made hereunder, Fair Market Value shall be deemed to be equal to the arithmetic mean between the reported high and low or closing bid and asked prices of a Share on the applicable date, or if no such trades were made that day then the most
recent date on which Shares were so traded. In the event Shares are not publicly traded at the time a determination of their value is required to be made hereunder, the determination of their Fair Market Value shall be made by the Committee in such
manner as it deems appropriate provided such manner is consistent with Treasury Regulation <FONT STYLE="white-space:nowrap">1.409A-1(b)(5)(iv)(B).</FONT> The Fair Market Value that the Committee determines shall be final, binding and conclusive on
the Company, any Affiliate and each Grantee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.37 &#147;<U>FICA</U>&#148; has the meaning set forth in Section&nbsp;16.1(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.38 &#147;<U>Grant Date</U>&#148; means the date on which an Award is granted or such later date as specified in advance by the Committee.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.39 &#147;<U>Grantee</U>&#148; means an Eligible Person to whom an Award has been granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.40 &#147;<U>Immediate Family</U>&#148; has the meaning set forth in Section&nbsp;5.4(c). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.41 &#147;<U>Incentive Stock Option</U>&#148; means an Option that is intended to meet the
requirements of Section&nbsp;422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.42 &#147;<U>Incumbent Board Member</U>&#148; means an individual who either is (a)&nbsp;a
member of the Board as of the effective date of the Board&#146;s adoption of this Plan or (b)&nbsp;a member who becomes a member of the Board subsequent to the date of the Board&#146;s adoption of this Plan whose election, or nomination for election
by the Company&#146;s stockholders, was approved by a vote of at least sixty percent (60%) of the then Incumbent Board Members (either by a specific vote or by approval of the proxy statement of the Company in which that person is named as a nominee
for director, without objection to that nomination), but excluding, for that purpose, any individual whose initial assumption of office occurs as a result of an actual or threatened election contest (within the meaning of Rule <FONT
STYLE="white-space:nowrap">14a-11</FONT> of the Exchange Act) with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.43 &#147;<U>LTD Program</U>&#148; has the meaning set forth in Section&nbsp;2.26(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.44 &#147;<U>Management Committee</U>&#148; has the meaning set forth in Section&nbsp;3.1(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.45 &#147;<U>More Than Ten Percent (10%) Owner</U>&#148; has the meaning set forth in Section&nbsp;6.4(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.46 &#147;<U>Nasdaq</U>&#148; means The Nasdaq Stock Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.47 &#147;<U>Net After Tax Receipt</U>&#148; has the meaning set forth in Article 17. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.48 &#147;<U><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</U>&#148; means a member of the Board, or the board of directors
of an Affiliate, who is not an employee of the Company or any Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.49 &#147;<U>Non-Qualified Stock Option</U>&#148; means an
option that is not intended to meet the requirements of Section&nbsp;422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.50 &#147;<U>Option</U>&#148; means an option
granted under Article 6 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.51 &#147;<U>Other Plans</U>&#148; has the meaning set forth in Section&nbsp;6.4(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.52 &#147;<U>Other Stock-Based Award</U>&#148; means a right, granted under Article 12 hereof, that relates to or is valued by reference to
Shares or other Awards relating to Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.53 &#147;<U>Overpayment</U>&#148; has the meaning set forth in Article 17. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.54 &#147;<U>Parent Corporation</U>&#148; means any parent corporation of the Company within the meaning of Section&nbsp;424(e) of the Code.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.55 &#147;<U>Performance-Based Award</U>&#148; means an Award with respect to which the grant, vesting, payment and/or settlement is
contingent upon the satisfaction of specified Performance Measures in the specified performance period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.56 &#147;<U>Performance
Measures</U>&#148; mean one or more performance measures established by the Committee as a requirement for an Award to vest and/or become exercisable or settled. An Award may be contingent upon the Grantee&#146;s continued employment or service in
addition to the Performance Measures. In determining if the Performance Measures have been achieved, the Committee will adjust the performance targets in the event of any unbudgeted acquisition, divestiture or other unexpected fundamental change in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the business of the Company, an Affiliate or business unit or in any product that is material taken as a whole as appropriate to fairly and equitably determine if the Award is to become
exercisable, nonforfeitable and transferable or earned and payable pursuant to the conditions set forth in the Award. Additionally, in determining if such performance conditions have been achieved, the Committee also will adjust the performance
targets in the event of any (i)&nbsp;unanticipated asset write-downs or impairment charges, (ii)&nbsp;litigation or claim judgments or settlements thereof, (iii)&nbsp;changes in tax laws, accounting principles or other laws or provisions affecting
reported results, (iv)&nbsp;accruals for reorganization or restructuring programs, or (v)&nbsp;other extraordinary <FONT STYLE="white-space:nowrap">non-reoccurring</FONT> items. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.57 &#147;<U>Performance Share</U>&#148; and &#147;<U>Performance Unit</U>&#148; mean an Award granted as a Performance Share or Performance
Unit under Article 10. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.58 &#147;<U>Period of Restriction</U>&#148; means the period during which Restricted Shares are subject to
Forfeiture if the conditions specified in the Award Agreement are not satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.59 &#147;<U>Period of Vesting</U>&#148; means the
period during which the Award is subject to forfeiture or may not be exercised if the conditions specified in the Award Agreement are not satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.60 &#147;<U>Permitted Transferee</U>&#148; has the meaning set forth in Section&nbsp;5.4(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.61 &#147;<U>Person</U>&#148; means any individual, sole proprietorship, partnership, joint venture, limited liability company, trust,
unincorporated organization, association, corporation, institution, public benefit corporation, entity or government instrumentality, division, agency, body or department. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.62 &#147;<U>Plan</U>&#148; means this ScanSource, Inc. 2024 Omnibus Incentive Compensation Plan, in its current form or as hereafter
amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.63 &#147;<U>Present Value</U>&#148; has the meaning set forth in Article 17. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.64 &#147;<U>Prior Grants</U>&#148; has the meaning set forth in Section&nbsp;6.4(e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.65 &#147;<U>Prior Plan</U>&#148; means the ScanSource, Inc. 2021 Omnibus Incentive Compensation Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.66 &#147;<U>Proceeding</U>&#148; has the meaning set forth in Section&nbsp;18.11. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.67 &#147;<U>Reduced Amount</U>&#148; has the meaning set forth in Article 17. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.68 &#147;<U>Restricted Shares</U>&#148; means Shares issued under Article 9 that are both subject to Forfeiture and are nontransferable if
the Grantee does not satisfy the conditions specified in the Award Agreement applicable to such Shares and subject to the Grantee paying the nominal value in cash for each Share to the extent required by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.69 &#147;<U>Restricted Stock Units</U>&#148; are rights, granted under Article 9, to receive Shares if the Grantee satisfies the conditions
specified in the Award Agreement applicable to such rights, and subject always to the Grantee paying the nominal value in cash for each such Share to the extent required by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.70 &#147;<U>Retirement</U>&#148; means a Grantee&#146;s Termination of Service on or after attaining such age and/or completing such years
of service as the Committee may determine and set forth in an Award Agreement, provided that such Termination of Service is not for Cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.71 &#147;<U>Returned Shares</U>&#148; has the meaning set forth in Section&nbsp;4.1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.72 &#147;<U>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></U>&#148; means Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT> promulgated by the SEC under the Exchange Act, as amended from time to time, together with any successor rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.73 &#147;<U>Sarbanes-Oxley</U>&#148; means the Sarbanes-Oxley Act of 2002. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.74 &#147;<U>SEC</U>&#148; means the United States Securities and Exchange Commission, or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.75 &#147;<U>Section</U><U></U><U>&nbsp;16 <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</U>&#148; means a member of the
Board who satisfies the requirements to qualify as a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; under Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.76 &#147;<U>Section</U><U></U><U>&nbsp;16 Person</U>&#148; means a person who is subject to potential liability under Section&nbsp;16(b) of
the Exchange Act with respect to transactions involving equity securities of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.77 &#147;<U>Securities Act</U>&#148; means
the Securities Act of 1933, as amended, and all rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.78 &#147;<U>Separation from
Service</U>&#148; means, with respect to any Award that constitutes deferred compensation within the meaning of Code Section&nbsp;409A, a &#147;separation from service&#148; as defined in Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.79 &#147;<U>Share</U>&#148; means the common stock, no par value per
share, of the Company, and, unless the context otherwise requires, such other securities of the Company, as may be substituted or resubstituted for Shares pursuant to Section&nbsp;4.2 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.80 &#147;<U>Stock Appreciation Right</U>&#148; or &#147;<U>SAR</U>&#148; means an Award granted under Article 7 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.81 &#147;<U>Subsidiary Corporation</U>&#148; means a corporation other than the Company in an unbroken chain of corporations beginning with
the Company if, at the time of granting the Award, each of the corporations other than the last corporation in the unbroken chain owns shares or stock possessing fifty percent (50%) or more of the total combined voting power of all classes of shares
or stock in one of the other corporations in such chain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.82 &#147;<U>Substitute Awards</U>&#148; has the meaning set forth in
Section&nbsp;5.6(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.83 &#147;<U>Surviving Company</U>&#148; means the surviving corporation in any merger or consolidation, involving
the Company, including the Company if the Company is the surviving corporation, or the direct or indirect parent company of the Company or such surviving corporation following a sale of substantially all of the outstanding shares or stock of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.84 &#147;<U>Tax Date</U>&#148; has the meaning set forth in Section&nbsp;16.1(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.85 &#147;<U>Tendered Restricted Shares</U>&#148; has the meaning set forth in Section&nbsp;6.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.86 &#147;<U>Term</U>&#148; of any Option or SAR means the period beginning on the Grant Date of an Option or SAR and ending on the date such
Option or SAR expires, terminates or is cancelled. No Option or SAR granted under this Plan shall have a Term exceeding 10 years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.87 &#147;<U>Termination of Service</U>&#148; means (a)&nbsp;that the employee has
terminated employment with the Company and its Affiliates, the <FONT STYLE="white-space:nowrap">non-employee</FONT> consultant is no longer serving as a consultant to the Company or an Affiliate or the
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director has ceased being a director of the Company or any Affiliate or (b)&nbsp;when an entity which is employing the employee or <FONT STYLE="white-space:nowrap">non-employee</FONT> consultant
or on whose board of directors the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director is serving, ceases to be an Affiliate, unless the Participant otherwise is, or thereupon becomes, an employee,
<FONT STYLE="white-space:nowrap">non-employee</FONT> consultant or <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director of the Company or another Affiliate, at the time such entity ceases to be an Affiliate. In the event an employee, <FONT
STYLE="white-space:nowrap">non-employee</FONT> consultant or <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director becomes one of the other categories of Eligible Persons upon the termination of such employee&#146;s employment, such
consultant&#146;s consultancy or such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s service, unless otherwise determined by the Committee, in its sole discretion, no Termination of Service will be deemed to have occurred until
such time as such person is no longer an employee, <FONT STYLE="white-space:nowrap">non-employee</FONT> consultant or <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director. Notwithstanding the foregoing, however, that if an Award constitutes
deferred compensation within the meaning of Code Section&nbsp;409A, Termination of Service with respect to such Award shall mean the Grantee&#146;s Separation from Service to the extent necessary for such Award to comply with Section&nbsp;409A of
the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.88 &#147;<U>Underpayment</U>&#148; has the meaning set forth in Article 17. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Administration </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1
<U>Committee</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to Article 12 and Section&nbsp;3.2, the Plan shall be administered by the Compensation
Committee or the Board itself if no Compensation Committee exists. Notwithstanding the foregoing, either the Board or the Compensation Committee may at any time and in one or more instances reserve administrative powers to itself as the Committee or
exercise any of the administrative powers of the Committee. To the extent the Board or Compensation Committee considers it desirable to comply with Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> the Committee shall consist of two or more
directors of the Company, all of whom qualify as &#147;independent directors&#148; within the meaning of the Nasdaq listing standards and as Section&nbsp;16 <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors. The number of members of the
Committee shall from time to time be increased or decreased, and shall be subject to such conditions, in each case if and to the extent the Board deems it appropriate to permit transactions in Shares pursuant to the Plan to satisfy such conditions
of Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Board or the Compensation Committee may appoint and
delegate to another committee (&#147;<U>Management Committee</U>&#148;), or to the CEO, any or all of the authority of the Board or the Committee, as applicable, with respect to Awards to Grantees other than Grantees who, at the time any such
delegated authority is exercised, are executive officers or <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, or who are (or are expected to be) Section&nbsp;16 Persons. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Unless the context requires otherwise, any references herein to &#147;Committee&#148; include references to, the Board or
the Compensation Committee to the extent the Board or the Compensation Committee, as applicable, has assumed or exercises administrative powers as the Committee pursuant to subsection (a), and to the Management Committee or the CEO to the extent
either has been delegated authority pursuant to subsection (b), as applicable; provided that, (i)&nbsp;for purposes of Awards to <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, &#147;Committee&#148; shall include only the full Board,
and (ii)&nbsp;for purposes of Awards intended to comply with Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> &#147;Committee&#148; shall include only the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Powers of Committee</U>. Subject to and consistent with the provisions of the Plan (including Article 14), the Committee has full and
final authority and sole discretion as follows; provided that any such authority or discretion exercised with respect to a specific <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director shall be approved by the affirmative vote of a majority
of the members of the Board, even if not a quorum, but excluding the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director with respect to whom such authority or discretion is exercised: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) to determine when, to whom and in what types and amounts Awards should
be granted; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) to grant Awards to Eligible Persons in any number and to determine the terms and conditions applicable to
each Award; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) subject to Section&nbsp;5.3 below,<B> </B>to determine whether, to what extent and under what
circumstances, subject to Applicable Law, an Award may be settled in, or the exercise price of an Award may be paid in, cash, Shares, other Awards or other property, or an Award may be accelerated, vested, canceled, forfeited or surrendered or any
terms of the Award may be waived, and to accelerate the exercisability of, and to accelerate or waive any or all of the terms and conditions applicable to, any Award or any group of Awards for any reason and at any time; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) to determine with respect to Awards granted to Eligible Persons whether, to what extent and under what circumstances cash,
Shares, other Awards, other property and other amounts payable with respect to an Award will be deferred, either at the election of the Grantee or if and to the extent specified in the Award Agreement automatically or at the election of the
Committee; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) subject to Section&nbsp;3.3 below, to offer to exchange or buy out any previously granted Award for a
payment in cash, Shares or other Award; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) subject to Section&nbsp;5.3 below,<B> </B>to provide in the terms of the Award
or otherwise for accelerated exercisability or vesting of any Award upon the occurrence of one or more events other than completion of a service period, including without limitation the Grantee&#146;s Retirement, death, Disability or Termination of
Service by the Company and its Affiliates without Cause or a Change in Control; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) to construe and interpret the Plan and
to make all determinations, including factual determinations, necessary or advisable for the administration of the Plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) to make, amend, suspend, waive and rescind rules and regulations relating to the Plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) to appoint such agents as the Committee may deem necessary or advisable to administer the Plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) with the consent of the Grantee, to amend any such Award Agreement at any time; provided, however, that the consent of the
Grantee shall not be required for any amendment (i)&nbsp;which does not adversely affect the rights of the Grantee, or (ii)&nbsp;which is necessary or advisable (as determined by the Committee) to carry out the purpose of the Award as a result of
any new Applicable Law or change in an existing Applicable Law, or (iii)&nbsp;to the extent the Award Agreement specifically permits amendment without consent; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) subject to Section&nbsp;3.3, to cancel, with the consent of the Grantee, outstanding Awards and to grant new Awards in
substitution therefor; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) to impose such additional terms and conditions upon the grant, exercise or retention of Awards
as the Committee may, before or concurrently with the grant thereof, deem appropriate, including limiting the percentage of Awards which may from time to time be exercised by a Grantee; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) to adopt rules and/or procedures (including the adoption of any subplan
under the Plan) relating to the operation and administration of the Plan to accommodate requirements of local law and procedures; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) to correct any defect or supply any omission or reconcile any inconsistency, and to construe and interpret the Plan, the
rules and regulations, and Award Agreement or any other instrument entered into or relating to an Award under the Plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) to modify, extend or renew an Award, subject to Section&nbsp;1.3, 5.3 and 5.9, provided, however, that such action does not
subject the Award to Section&nbsp;409A of the Code without the consent of the Grantee; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) subject to Section&nbsp;3.3, to
provide for the settlement of any Award in cash, Shares or a combination thereof; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) to take any other action with
respect to any matters relating to the Plan for which it is responsible and to make all other decisions and determinations as may be required under the terms of the Plan or as the Committee may deem necessary or advisable for the administration of
the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any action of the Committee with respect to the Plan shall be final, conclusive and binding on all persons. The express grant
of any specific power to the Committee, and the taking of any action by the Committee, shall not be construed as limiting any power or authority of the Committee. The Committee may delegate to officers or managers of the Company or any Affiliate the
authority, subject to such terms as the Committee shall determine, to perform specified functions under the Plan (subject to Sections 4.3 and 5.7(c)). The Committee may revoke or amend the terms of any delegation at any time but such action shall
not invalidate any prior actions of the Committee&#146;s delegate or delegates that were consistent with the terms of the Plan and the Committee&#146;s prior delegation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall bear all expenses of administering the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any provision of the Plan to the contrary, the Committee, in its sole discretion, may modify the terms and conditions of the
Plan and/or any Award granted to Grantees outside the United States to comply with applicable foreign laws or listing requirements of any such foreign stock exchange; and take any action, before or after an Award is made, that it deems advisable to
obtain approval or comply with any necessary local governmental regulatory exemptions or approvals or listing requirements of any such foreign stock exchange. Notwithstanding the foregoing, the Committee may not take any actions hereunder, and no
Awards shall be granted, that would violate the Exchange Act or any other securities law or governing statute or any other Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>No Repricings</U>. Notwithstanding any provision in Section&nbsp;3.2 to the contrary, the terms of any outstanding Option or SAR may
not be amended to reduce the Exercise Price of such Option or SAR, or cancel any outstanding Option or SAR in exchange for other Options or SARs with an Exercise Price that is less than the Exercise Price of the cancelled Option or SAR or for any
cash payment (or Shares having a Fair Market Value) in an amount that exceeds the excess of the Fair Market Value of the Shares underlying such cancelled Option or SAR over the aggregate Exercise Price of such Option or SAR or for any other Award,
without stockholder approval; provided, however, that the restrictions set forth in this Section&nbsp;3.3, shall not apply (i)&nbsp;unless the Company has a class of shares or stock that is registered under Section&nbsp;12 of the Exchange Act or
(ii)&nbsp;to any adjustment allowed under Section&nbsp;4.2. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 4 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Shares Subject to the Plan and Maximum Awards </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Number of Shares Available for Grants</U>. Subject to adjustment as provided in Section&nbsp;4.2 and except as provided in
Section&nbsp;5.6(b), the maximum number of Shares hereby reserved for delivery in connection with Awards under the Plan shall be 2,234,543 Shares, plus that number of Shares subject to awards granted under the Prior Plan which become available in
accordance with the provisions below after the stockholders of the Company approve the Plan. The total number of Shares that may be delivered pursuant to the exercise of Incentive Stock Options granted hereunder, however, shall not exceed 2,234,543.
If the stockholders of the Company approve the Plan, no further awards shall be granted under the Prior Plan after the date of such approval; if the stockholders of the Company do not approve the Plan, the Prior Plan shall remain in effect for the
grant of awards thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares covered by an Award shall only be counted as used to the extent actually used. A Share issued in
connection with an Award under the Plan shall reduce the total number of Shares available for issuance under the Plan by one; provided, however, that, upon settlement of a stock-settled SAR, the gross number of Shares underlying the SAR that is
exercised will be treated as having been delivered for purposes of determining the maximum number of Shares available for grant under the Plan and shall not again be treated as available for grant under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Award under the Plan or any award under the Prior Plan that is outstanding as of the Effective Date terminates without the delivery of
Shares, whether by lapse, forfeiture, cancellation or otherwise, the Shares subject to such Award or the award under the Prior Plan, to the extent of any such termination, shall again be available for grant under the Plan. Notwithstanding the
foregoing, upon the exercise of any Award or any award under the Prior Plan that is outstanding as of the Effective Date granted in tandem with any other Award or any other award under the Prior Plan, such related Award or related award under the
Prior Plan shall be cancelled to the extent of the number of Shares as to which the Award or the award under the Prior Plan<B> </B>is exercised and such number of Shares shall no longer be available for Awards under the Plan. If any Shares subject
to an Award granted hereunder or any award granted under the Prior Plan that is outstanding as of the Effective Date are withheld or applied as payment in connection with the exercise of such Award or of such award under the Prior Plan or the
withholding or payment of taxes related thereto or Shares separately surrendered by the Grantee for any such purpose (&#147;<U>Returned Shares</U>&#148;), such Returned Shares will be treated as having been delivered for purposes of determining the
maximum number of Shares available for grant under the Plan and shall not again be treated as available for grant under the Plan. The number of Shares available for issuance under the Plan may not be increased through the Company&#146;s purchase of
Shares on the open market with the proceeds obtained from the exercise of any Options or other purchase rights granted hereunder or any options or other purchase rights granted under the Prior Plan. In addition, in the case of any Substitute Award
granted in assumption of or in substitution for an Acquired Entity Award, Shares delivered or deliverable in connection with such Substitute Award shall not be counted against the number of Shares reserved under the Plan (to the extent permitted by
the rules of Nasdaq and any other stock exchange or automated quotation system upon which the Shares are listed or quoted), and available shares of stock under a stockholder-approved plan of an Acquired Entity (as appropriately adjusted to reflect
the transaction) also may be used for Awards under the Plan, which shall not reduce the number of Shares otherwise available under the Plan (subject to applicable requirements of Nasdaq and any other stock exchange or automated quotation system upon
which the Shares are listed or quoted). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares may be allotted and issued pursuant to the Plan from the Company&#146;s authorized
but unissued share capital, or the reissue of treasury Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proceeds that the Company receives in connection with Awards granted
under the Plan, if any, shall be used for general corporate purposes and shall be added to the general funds of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2
<U>Adjustments in Authorized Shares and Awards; Liquidation, Dissolution or Change in Control</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In the event that
the Committee determines that any dividend or other distribution (excluding any ordinary dividend or distribution) (whether in the form of cash, Shares, or other property), recapitalization, forward or reverse stock split, subdivision, consolidation
or reduction of capital, reorganization, merger, consolidation, scheme of arrangement, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off</FONT> or combination involving the Company or repurchase or exchange
of Shares or other securities of the Company or other rights to purchase Shares or other securities of the Company, or other corporate transaction or event affects the Shares, such that any adjustment is determined by the Committee to be appropriate
in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan, then the Committee shall, in such manner as it may deem equitable, adjust any or all of (i)&nbsp;the number and type of
Shares (or other securities or property) with respect to which Awards may be granted, (ii)&nbsp;the number and type of Shares (or other securities or property) subject to outstanding Awards, (iii)&nbsp;the Exercise Price with respect to any Award
or, if deemed appropriate, make provision for a cash payment to the holder of an outstanding Award, (iv)&nbsp;the number and kind of Shares of outstanding Restricted Shares, or the Shares underlying any Award of Restricted Stock Units, Deferred
Stock or other outstanding Share-based Award and (v)&nbsp;any other terms and conditions of the Award. Notwithstanding the foregoing, (x)&nbsp;no such adjustment shall be authorized with respect to any Options or SARs to the extent that such
adjustment would cause the Option or SAR (determined as if such Option or SAR was an Incentive Stock Option) to violate Section&nbsp;424(a) of the Code or with respect to any Awards to the extent such adjustment would subject any Grantee to taxation
under Section&nbsp;409A of the Code; and (y)&nbsp;the number of Shares subject to any Award denominated in Shares shall always be a whole number. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event of a merger or consolidation of the Company with or into another corporation or a sale of all or substantially
all of the shares or stock of the Company or all or substantially all of the assets of the Company, including by way of a court sanctioned compromise or scheme of arrangement, reorganization, merger, combination, purchase, recapitalization,
liquidation, or sale, transfer, exchange or other disposition (a &#147;<U>Corporate Transaction</U>&#148;) that results in a Change in Control, unless an outstanding Award is assumed by the Surviving Company or replaced with an equivalent Award
granted by the Surviving Company in substitution for such outstanding Award, the Committee shall cancel any outstanding Awards that are not vested and nonforfeitable as of the consummation of such Corporate Transaction (unless the vesting of the
Award is accelerated as described below) and with respect to any vested and nonforfeitable Awards, the Committee may either (i)&nbsp;allow all Grantees to exercise such Awards in the nature of Options, SARs or other purchase rights to the extent
then exercisable or to become exercisable upon the Change in Control within a reasonable period prior to the consummation of the Change in Control and cancel any Awards in the nature of Options, SARs or other purchase rights that remain unexercised
upon consummation of the Change in Control, and/or (ii)&nbsp;cancel any or all of such outstanding Awards in exchange for a payment (in cash and/or in securities and/or other property) in an amount equal to the amount that the Grantee would have
received (net of the Exercise Price with respect to any Awards in the nature of Options, SARs or other purchase rights) and on the same terms (including without limitation any <FONT STYLE="white-space:nowrap">earn-out,</FONT> escrow or other
deferred consideration </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
provisions) as if such vested Awards were settled or distributed or such Awards in the nature of vested Options, SARs or other purchase rights were exercised immediately prior to the consummation
of the Change in Control. Notwithstanding the foregoing, if an Option, SAR or other purchase right is not assumed by the Surviving Company or replaced with an equivalent Award issued by the Surviving Company and the Exercise Price with respect to
the outstanding Option, SAR or other purchase right equals or exceeds the amount payable per Share in the Change in Control, such Awards shall be cancelled without any payment to the Grantee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Immediately prior to consummation of any Corporate Transaction that results in a Change in Control (subject to consummation
of the Change in Control), all outstanding Awards will become vested and <FONT STYLE="white-space:nowrap">non-forfeitable,</FONT> earned and payable and any conditions on any such Award shall lapse, as to all of such Award to the extent then
outstanding, including Shares as to which the Award would not otherwise be exercisable or <FONT STYLE="white-space:nowrap">non-forfeitable</FONT> or earned and payable, unless the outstanding Award is assumed by the Surviving Company or replaced
with an equivalent Award granted by the Surviving Company in substitution for such outstanding Award. If the outstanding Award is assumed by the Surviving Company or replaced with an equivalent Award granted by the Surviving Company in substitution
for such outstanding Award, then all such outstanding Awards will become vested and <FONT STYLE="white-space:nowrap">non-forfeitable,</FONT> earned and payable and any conditions on any such Award shall lapse, as to all of such Award to the extent
then outstanding, including Shares as to which the Award would not otherwise be exercisable or <FONT STYLE="white-space:nowrap">non-forfeitable</FONT> or earned and payable, upon the Grantee&#146;s subsequent Retirement, death, Disability, or
Termination of Service by the Company and its Affiliates without Cause, in any such case on or within the two (2)&nbsp;years after the Change in Control. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding the forgoing provisions of this Section&nbsp;4.2, if an Award constitutes deferred compensation within the
meaning of Code Section&nbsp;409A, no payment or settlement of such Award shall be made pursuant to Section&nbsp;4.2(b) or (c), unless the Corporate Transaction or the dissolution or liquidation of the Company, as applicable, constitutes a change in
ownership or effective control of the Company or a change in ownership of a substantial portion of the assets of the Company as described in Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT> and such payment or
settlement does not result in a violation of Section&nbsp;409A of the Code. Additionally, with respect to any Award with respect to which the grant, vesting, payment and/or settlement is contingent upon the satisfaction of specified Performance
Measures in the specified performance period and which is not assumed by the Surviving Company or replaced with an equivalent Award granted by the Surviving Company in substitution for such outstanding Award, unless the Award Agreement provides
otherwise, the Award shall become vested, and be paid and settled, pursuant to Section&nbsp;4.2(b) or (c), at target and prorated based on the number of days in the specified performance period prior to and including the date of the Change in
Control over the number of days in the specified performance period. If any such Awards are assumed by the Surviving Company or replaced with an equivalent Award granted by the Surviving Company in substitution for such outstanding Award, unless the
Award Agreement provides otherwise, the Award shall be converted into a time-based Award as of the Change in Control, subject to the Grantee&#146;s continued employment or other service, and such outstanding Awards will become vested and <FONT
STYLE="white-space:nowrap">non-forfeitable,</FONT> earned and payable and any conditions on any such Award shall lapse, as to all of such Award to the extent then outstanding, including Shares as to which the Award would not otherwise be exercisable
or <FONT STYLE="white-space:nowrap">non-forfeitable</FONT> or earned and payable, upon the Grantee&#146;s subsequent Retirement, death, Disability, or Termination of Service by the Company and its Affiliates without Cause, in any such case on or
within the two (2)&nbsp;years after the Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Individual Award Limits</U>. Except as provided herein or in Section&nbsp;5.6(b), no
Grantee (other than a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director) may be granted in a single calendar year any Awards denoted in Shares as of the date of grant (regardless of whether the Awards will be settled in Shares, cash or
other property) with respect to more than 500,000 Shares (twice that limit for Awards that are granted to a Grantee (other than a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director) in the calendar year in which the Grantee first
commences employment or service) (based on the highest level of performance resulting in the maximum payout), subject to adjustment as provided in Section&nbsp;4.2(a). The maximum potential value of any Awards denoted in cash or other property as of
the date of grant (with the property valued as of the date of grant of the Award) (regardless of whether the Awards will be settled in Shares, cash or other property) that may be granted in any calendar year to any Grantee (other than a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director) shall not exceed $7,000,000 (twice that limit for Awards that are granted to a Grantee (other than a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director) in the calendar year in
which the Grantee first commences employment or service) (based on the highest level of performance resulting in the maximum payout) for all such Awards. Such annual limitations apply to Dividend Equivalents under Article 11 only if such Dividend
Equivalents are granted separately from and not as a feature of another Award (even if that feature is treated as a separate award for other purposes, including Section&nbsp;409A of the Code). Notwithstanding the foregoing, however, the Committee
may make exceptions to the foregoing limits in extraordinary or unusual circumstances as the Committee may determine appropriate. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 5 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Eligibility
and General Conditions of Awards </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Eligibility</U>. The Committee may in its discretion grant Awards to any Eligible Person,
whether or not he or she has previously received an Award; provided, however, that all Awards made to <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors shall be determined by the Board in its sole discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Award Agreement</U>. To the extent not set forth in the Plan, the terms and conditions of each Award shall be set forth in an Award
Agreement and, unless the Committee determines otherwise, such Agreement must be signed, acknowledged and returned by the Grantee to the Company. Unless the Committee determines otherwise, any failure by the Grantee to sign and return the Agreement
within such period of time following the granting of the Award as the Committee shall prescribe shall cause such Award to the Grantee to be null and void. By accepting an Award or other benefits under the Plan (including participation in the Plan),
each Grantee shall be conclusively deemed to have indicated acceptance and ratification of, and consented to, all provisions of the Plan and the Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>General Terms and Termination of Service</U>. The Committee may impose on any Award or the exercise or settlement thereof, at the date
of grant or, subject to the provisions of Section&nbsp;14.2, thereafter, such additional terms and conditions not inconsistent with the provisions of the Plan as the Committee shall determine, including without limitation terms requiring forfeiture
or transfer, acceleration or <FONT STYLE="white-space:nowrap">pro-rata</FONT> acceleration of Awards in the event of a Termination of Service by the Grantee. Awards may be granted for no consideration other than prior and future services save that
in no event will Shares subject to an Award be allotted and issued unless the nominal value per Share is paid in cash, to the extent required by Applicable Law. Except as otherwise determined by the Committee pursuant to this Section&nbsp;5.3 or set
forth in an Award Agreement, all Options that have not been exercised, or any other Awards that remain subject to a risk of forfeiture or which are not otherwise vested, or which have outstanding Performance Periods, at the time of a Termination of
Service shall be forfeited to the Company. Notwithstanding any other provision of the Plan to the contrary and subject to the immediately following proviso, equity-based Awards granted under the Plan shall vest no earlier than the first anniversary
of the date the Award is granted, and performance-based Awards must have a performance period of at least one year; provided, however, that (i)&nbsp;the Committee may grant Awards without regard to the foregoing minimum vesting requirement with
respect to a maximum of five percent (5%) of the available Shares (the &#147;<U>5% Exception Limit</U>&#148;) authorized for issuance under the Plan (subject to adjustment under Section&nbsp;4.2) and (ii)&nbsp;Awards granted within the first ninety
(90)&nbsp;days of a year may have a performance period that begins as of the first day of the year and still qualify as having a performance period of at least one year. For the avoidance of doubt, the foregoing
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
restriction does not apply to the Committee&#146;s discretion to provide in the terms of the Award or otherwise for accelerated exercisability or vesting of any Award upon the occurrence of one
or more events other than completion of a service period, including without limitation the Grantee&#146;s Retirement, death, Disability, Termination of Service by the Company and its Affiliates without Cause or a Change in Control.<B>
</B>Additionally, notwithstanding any other provision of this Plan or any Award Agreement to the contrary, no dividends or Dividend Equivalents shall be paid with respect to any Awards that do not become vested,
<FONT STYLE="white-space:nowrap">non-forfeitable</FONT> or payable under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Nontransferability of Awards</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Award and each right under any Award shall be exercisable only by the Grantee during the Grantee&#146;s lifetime, or,
if permissible under Applicable Law, by the Grantee&#146;s guardian or legal representative or by a transferee receiving such Award pursuant to a domestic relations order (a &#147;<U>DRO</U>&#148;) as defined in the Code or Title I of the Employee
Retirement Income Security Act of 1974, as amended (&#147;<U>ERISA</U>&#148;), or the rules thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) No Award
(prior to the time, if applicable, Shares are delivered in respect of such Award), and no right under any Award, may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by a Grantee otherwise than by will or by the
laws of descent and distribution (or in the case of Restricted Shares, to the Company) or pursuant to a DRO, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the
Company or any Affiliate; provided that the designation of a beneficiary to receive benefits in the event of the Grantee&#146;s death shall not constitute an assignment, alienation, pledge, attachment, sale, transfer or encumbrance. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding subsections (a)&nbsp;and (b) above, to the extent provided in the Award Agreement, Awards (other than
Incentive Stock Options and corresponding tandem Awards), may be transferred, without consideration, to a Permitted Transferee. For this purpose, a &#147;<U>Permitted Transferee</U>&#148; in respect of any Grantee means any member of the Immediate
Family of such Grantee, any trust of which all of the primary beneficiaries are such Grantee or members of his or her Immediate Family, or any partnership (including limited liability companies and similar entities) of which all of the partners or
members are such Grantee or members of his or her Immediate Family; and the &#147;<U>Immediate Family</U>&#148; of a Grantee means the Grantee&#146;s spouse, any person sharing the Grantee&#146;s household (other than a tenant or employee),
children, stepchildren, grandchildren, parents, stepparents, siblings, grandparents, nieces and nephews. Such Award may be exercised by such transferee in accordance with the terms of the Award Agreement. If so determined by the Committee, a Grantee
may, in the manner established by the Committee, designate a beneficiary or beneficiaries to exercise the rights of the Grantee, and to receive any distribution with respect to any Award, after the death of the Grantee. A transferee, beneficiary,
guardian, legal representative or other person claiming any rights under the Plan from or through any Grantee shall be subject to and consistent with the provisions of the Plan and any applicable Award Agreement, except to the extent the Plan and
Award Agreement otherwise provide with respect to such persons, and to any additional restrictions or limitations deemed necessary or appropriate by the Committee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing herein shall be construed as requiring the Company or any Affiliate to honor a DRO except to the extent required
under Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>Cancellation and Rescission of Awards</U>. Unless the Award Agreement specifies otherwise, the Committee may
cancel, rescind, suspend, withhold, or otherwise limit or restrict any unexercised or other Award at any time if the Grantee is not in compliance with all applicable provisions of the Award Agreement and the Plan or if the Grantee has a Termination
of Service. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>Stand-Alone, Tandem and Substitute Awards</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Awards granted under the Plan may, in the discretion of the Committee, be granted either alone or in addition to, in tandem
with, or in substitution for, any other Award granted under the Plan unless such tandem or substitution Award would subject the Grantee to tax penalties imposed under Section&nbsp;409A of the Code. If an Award is granted in substitution for another
Award or any <FONT STYLE="white-space:nowrap">non-Plan</FONT> award or benefit, the Committee shall require the surrender of such other Award or <FONT STYLE="white-space:nowrap">non-Plan</FONT> award or benefit in consideration for the grant of the
new Award. Awards granted in addition to or in tandem with other Awards or <FONT STYLE="white-space:nowrap">non-Plan</FONT> awards or benefits may be granted either at the same time as or at a different time from the grant of such other Awards or <FONT
STYLE="white-space:nowrap">non-Plan</FONT> awards or benefits; provided, however, that if any SAR is granted in tandem with an Incentive Stock Option, such SAR and Incentive Stock Option must have the same Grant Date, Term and the Exercise Price of
the SAR may not be less than the Exercise Price of the related Incentive Stock Option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Committee may, in its
discretion and on such terms and conditions as the Committee considers appropriate in the circumstances, grant Awards under the Plan (&#147;<U>Substitute Awards</U>&#148;) in substitution for share or stock and share or stock-based awards
(&#147;<U>Acquired Entity Awards</U>&#148;) held by current or former employees or <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of, or consultants to, another corporation or entity who become Eligible Persons as the result of a
merger or consolidation of the employing corporation or other entity (the &#147;<U>Acquired Entity</U>&#148;) with the Company or an Affiliate or the acquisition by the Company or an Affiliate of property or shares or stock of the Acquired Entity
immediately prior to such merger, consolidation or acquisition in order to preserve for the Grantee the economic value of all or a portion of such Acquired Entity Award at such price as the Committee determines necessary to achieve preservation of
economic value. The limitations of Sections 4.1 and 4.3 on the number of Shares reserved or available for grants shall not apply to Substitute Awards granted under this Section&nbsp;5.6(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U>Deferral of Award Payouts</U>. The Committee may permit a Grantee to defer, or if and to the extent specified in an Award Agreement
require the Grantee to defer, receipt of the payment of cash or the delivery of Shares that would otherwise be due by virtue of the lapse or waiver of restrictions with respect to Awards, the satisfaction of any requirements or goals with respect to
Awards, the lapse or waiver of the deferral period for Awards, or the lapse or waiver of restrictions with respect to Awards. If the Committee permits such deferrals, the Committee shall establish rules and procedures for making such deferral
elections and for the payment of such deferrals, which shall conform in form and substance with applicable regulations promulgated under Section&nbsp;409A of the Code so that the Grantee is not subjected to tax penalties under Section&nbsp;409A of
the Code with respect to such deferrals. Except as otherwise provided in an Award Agreement, any payment or any Shares that are subject to such deferral shall be made or delivered to the Grantee as specified in the Award Agreement or pursuant to the
Grantee&#146;s deferral election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <U>Extension of Term of Award</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any provision of the Plan providing for the maximum term of an Award, in the event any Award would expire
prior to exercise, vesting or settlement because trading in Shares is prohibited by law or by any insider trading policy of the Company, the Committee may extend the term of the Award (or provide for such in the applicable Award Agreement) until
thirty (30)&nbsp;days after the expiration of any such prohibitions to permit the Grantee to realize the value of the Award, provided such extension (i)&nbsp;is permitted by law, (ii)&nbsp;does not violate Code Section&nbsp;409A with respect to any
Award, and (iii)&nbsp;does not otherwise adversely impact the tax consequences of the Award (such as with respect to incentive stock options and related Awards). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) This Section&nbsp;5.8(b) applies to an Option or SAR if (i)&nbsp;the
Grantee to whom the Option or SAR was granted remains in the continuous employment or service of the Company or an Affiliate from the date the Option or SAR was granted until the expiration date of such Option or SAR, (ii)&nbsp;on the expiration
date the Fair Market Value of a share exceeds the exercise price of the Option or SAR, (iii)&nbsp;the Option or SAR has become exercisable on or before the expiration date and (iv)&nbsp;the term of the Option or SAR will not be extended as described
above. In that event, each Option or SAR to which this Section&nbsp;5.8(b) applies shall be exercised automatically on the expiration date to the extent that it is outstanding and unexercised on such date. An Option that is exercised pursuant to
this Section&nbsp;5.8(b) shall result in the issuance to the Grantee of that number of whole Shares that have a Fair Market Value that most nearly equals, but does not exceed, the excess of the Fair Market Value of a Share on the expiration date
over the Option exercise price multiplied by the number of Shares subject to the exercisable portion of the Option. A SAR that is exercised pursuant to this Section&nbsp;5.8(b) shall be settled in accordance with its terms on the expiration date.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <U>Conditions on Delivery of Shares</U>. The Company will not be obligated to deliver any Shares under the Plan or remove
restrictions from Shares previously delivered under the Plan until (i)&nbsp;all Award conditions have been met or removed to the Company&#146;s satisfaction, (ii)&nbsp;as determined by the Company, all other legal matters regarding the issuance and
delivery of such Shares have been satisfied, including any applicable securities laws and rules and regulations of Nasdaq and any other stock exchange or automated quotation system upon which the Shares are listed or quoted, and (iii)&nbsp;the
Grantee has executed and delivered to the Company such representations or agreements as the Committee deems necessary or appropriate to satisfy any Applicable Laws. The Company&#146;s inability to obtain authority from any regulatory body having
jurisdiction, which the Committee determines is necessary to the lawful issuance and sale of any Shares, will relieve the Company of any liability for failing to issue or sell such Shares as to which such requisite authority has not been obtained.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 6 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Stock
Options </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <U>Grant of Options</U>. Subject to and consistent with the provisions of the Plan, Options may be granted to any
Eligible Person in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2
<U>Award Agreement</U>. Each Option grant shall be evidenced by an Award Agreement that shall specify the Exercise Price, the Term of the Option, the number of Shares to which the Option pertains, the time or times at which such Option shall be
exercisable, whether the Option is intended to be a Non-Qualified Stock Option or an Incentive Stock Option and such other provisions as the Committee shall determine. Except as otherwise set forth in Section&nbsp;5.6(b) above, no Option shall have
a term of more than ten (10)&nbsp;years after its Grant Date, subject to earlier termination as provided herein or in the applicable Award Agreement. No Option may be exercised at a time when such exercise and/or the issuance of Shares pursuant to
such exercise would be in breach of Applicable Law. No dividend rights or Dividend Equivalents may be granted in conjunction with any grant of Options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <U>Option Exercise Price</U>. The Exercise Price of an Option under this Plan shall be determined in the sole discretion of the Committee
but may not be less than one hundred percent (100%) of the Fair Market Value of a Share on the Grant Date (except as otherwise set forth in Section&nbsp;5.6(b) above) and shall not be less than the nominal value per Share if required by Applicable
Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4 <U>Grant of Incentive Stock Options</U>. At the time of the grant of any Option, the
Committee may in its discretion designate that such Option shall be made subject to additional restrictions to permit it to qualify as an Incentive Stock Option. An Option designated as an Incentive Stock Option: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) shall be granted only to an employee of the Company, a Parent Corporation or a Subsidiary Corporation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) shall have an Exercise Price of not less than one hundred percent (100%) of the Fair Market Value of a Share on the Grant
Date, and, if granted to a person who owns capital stock (including stock treated as owned under Section&nbsp;424(d) of the Code) possessing more than ten percent (10%) of the total combined voting power of all classes of capital stock of the
Company or any Subsidiary Corporation (a &#147;<U>More Than Ten Percent (10%) Owner</U>&#148;), have an Exercise Price not less than one hundred and ten percent (110%) of the Fair Market Value of a Share on its Grant Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) shall be for a period of not more than 10 years (five years if the Grantee is a More Than 10% Owner) from its Grant Date,
and shall be subject to earlier termination as provided herein or in the applicable Award Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) shall not have an
aggregate Fair Market Value (as of the Grant Date) of the Shares with respect to which Incentive Stock Options (whether granted under the Plan or any other stock option plan of the Grantee&#146;s employer or any parent or Subsidiary Corporation
(&#147;<U>Other Plans</U>&#148;)) are exercisable for the first time by such Grantee during any calendar year (&#147;<U>Current Grant</U>&#148;), determined in accordance with the provisions of Section&nbsp;422 of the Code, which exceeds $100,000
(the &#147;<U>$100,000 Limit</U>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) shall, if the aggregate Fair Market Value of the Shares (determined on the
Grant Date) with respect to the Current Grant and all Incentive Stock Options previously granted under the Plan and any Other Plans which are exercisable for the first time during a calendar year (&#147;<U>Prior Grants</U>&#148;) would exceed the
$100,000 Limit, be, as to the portion in excess of the $100,000 Limit, exercisable as a separate option that is not an Incentive Stock Option at such date or dates as are provided in the Current Grant; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) shall require the Grantee to notify the Committee of any disposition of any Shares delivered pursuant to the exercise of
the Incentive Stock Option under the circumstances described in Section&nbsp;421(b) of the Code (relating to holding periods and certain disqualifying dispositions) (&#147;<U>Disqualifying Disposition</U>&#148;) within 10 days of such a
Disqualifying Disposition; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) shall by its terms not be assignable or transferable other than by will or the laws of
descent and distribution and may be exercised, during the Grantee&#146;s lifetime, only by the Grantee; provided, however, that the Grantee may, to the extent provided in the Plan in any manner specified by the Committee, designate in writing a
beneficiary to exercise his or her Incentive Stock Option after the Grantee&#146;s death; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) shall, if such Option
nevertheless fails to meet the foregoing requirements, or otherwise fails to meet the requirements of Section&nbsp;422 of the Code for an Incentive Stock Option, be treated for all purposes of this Plan, except as otherwise provided in subsections
(d)&nbsp;and (e) above, as an Option that is not an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing and Section&nbsp;3.2, the
Committee may, without the consent of the Grantee, at any time before the exercise of an Option (whether or not an Incentive Stock Option), take any action necessary to prevent such Option from being treated as an Incentive Stock Option. No Option
that is intended to be an Incentive Stock Option shall be invalid for failure to qualify as an Incentive Stock Option. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5 <U>Payment of Exercise Price</U>. Except as otherwise provided by the Committee in an
Award Agreement, Options shall be exercised by the delivery of a written notice of exercise to the Company, setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full payment for the Shares made by
any one or more of the following means: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) cash, personal check, cash equivalent or wire transfer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) subject to Applicable Law and with the approval of the Committee, by delivery of Shares owned by the Grantee prior to
exercise, valued at their Fair Market Value on the date of exercise; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) subject to Applicable Law and with the approval
of the Committee, Shares acquired upon the exercise of such Option, such Shares valued at their Fair Market Value on the date of exercise; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) subject to Applicable Law and with the approval of the Committee, Restricted Shares held by the Grantee prior to the
exercise of the Option, each such share valued at the Fair Market Value of a Share on the date of exercise; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) subject
to Applicable Law (including the prohibited loan provisions of Section&nbsp;402 of Sarbanes-Oxley), through the sale of the Shares acquired on exercise of the Option through a broker-dealer to whom the Grantee has submitted an irrevocable notice of
exercise and irrevocable instructions to deliver promptly to the Company the amount of sale proceeds sufficient to pay for such Shares, together with, if requested by the Company, the amount of federal, state, local or foreign withholding taxes
payable by Grantee by reason of such exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Committee may in its discretion specify that, if any Restricted Shares
(&#147;<U>Tendered Restricted Shares</U>&#148;) are used to pay the Exercise Price, (x)&nbsp;all the Shares acquired on exercise of the Option shall be subject to the same restrictions as the Tendered Restricted Shares, determined as of the date of
exercise of the Option, or (y)&nbsp;a number of Shares acquired on exercise of the Option equal to the number of Tendered Restricted Shares shall be subject to the same restrictions as the Tendered Restricted Shares, determined as of the date of
exercise of the Option. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 7 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Stock Appreciation Rights </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <U>Issuance</U>. Subject to and consistent with the provisions of the Plan, the Committee, at any time and from time to time, may grant
SARs to any Eligible Person either alone or in addition to other Awards granted under the Plan. Such SARs may, but need not, be granted in connection with a specific Option granted under Article 6. The Committee may impose such conditions or
restrictions on the exercise of any SAR as it shall deem appropriate. No dividend rights or Dividend Equivalents may be granted in conjunction with any grant of SARs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Award Agreements</U>. Each SAR grant shall be evidenced by an Award Agreement in such form as the Committee may approve and shall
contain such terms and conditions not inconsistent with other provisions of the Plan as shall be determined from time to time by the Committee. Except as otherwise set forth in Section&nbsp;5.6(b) above, no SAR shall have a term of more than ten
(10)&nbsp;years after its Grant Date, subject to earlier termination as provided herein or in the applicable Award Agreement. No SAR may be exercised at a time when such exercise and/or the issuance of Shares pursuant to such exercise would be in
breach of Applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>SAR Exercise Price</U>. The Exercise Price of a SAR shall be determined by the
Committee in its sole discretion; provided that, except as otherwise set forth in Section&nbsp;5.6(b), the Exercise Price shall not be less than one hundred percent (100%) of the Fair Market Value of a Share on the date of the grant of the SAR (or
the exercise price of the related Option if granted in tandem therewith). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <U>Exercise and Payment</U>. Upon the exercise of a SAR, a
Grantee shall be entitled to receive payment from the Company in an amount determined by multiplying (a)&nbsp;the excess of the Fair Market Value of a Share on the date of exercise over the Exercise Price; by (b)&nbsp;the number of Shares with
respect to which the SAR is exercised. SARs shall be deemed exercised on the date written notice of exercise in a form acceptable to the Committee is received by the Secretary of the Company. The Company shall make payment in respect of any SAR
within thirty (30)&nbsp;days of the date the SAR is exercised, unless the Award Agreement specifically provides otherwise. Any payment by the Company in respect of a SAR may be made in cash, Shares, other property, or any combination thereof, as the
Committee, in its sole discretion, shall determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5 <U>Grant Limitations</U>. The Committee may at any time impose any other
limitations upon the exercise of SARs which, in the Committee&#146;s sole discretion, are necessary or desirable in order for Grantees to qualify for an exemption from Section&nbsp;16(b) of the Exchange Act. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 8 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Restricted
Shares </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 <U>Grant of Restricted Shares</U>. Subject to and consistent with the provisions of the Plan, the Committee, at any time
and from time to time, may grant Restricted Shares to any Eligible Person in such amounts as the Committee shall determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <U>Award
Agreement</U>. Each grant of Restricted Shares shall be evidenced by an Award Agreement that shall specify the Period(s) of Restriction, the number of Restricted Shares granted, and such other provisions as the Committee shall determine. The
Committee may impose such conditions and/or restrictions on any Restricted Shares granted pursuant to the Plan as it may deem advisable, including restrictions based upon the achievement of specific time-based restrictions, Performance Measures,
time-based restrictions on vesting following the attainment of the Performance Measures, and/or restrictions under Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3
<U>Consideration for Restricted Shares</U>. The Committee shall determine the amount, if any, that a Grantee shall pay for Restricted Shares provided that it shall be no less than the nominal value per Restricted Share if required to be paid by
Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 <U>Effect of Forfeiture</U>. If Restricted Shares are forfeited, and if the Grantee was required to pay for such
shares or acquired such Restricted Shares upon the exercise of an Option, the Grantee shall be deemed to have resold such Restricted Shares to the Company at a price equal to the lesser of (x)&nbsp;the amount paid by the Grantee for such Restricted
Shares, or (y)&nbsp;the Fair Market Value of a Share on the date of such forfeiture. The Company shall pay to the Grantee the deemed sale price as soon as is administratively practical. Such Restricted Shares shall cease to be outstanding and shall
no longer confer on the Grantee thereof any rights as a stockholder of the Company, from and after the date of the event causing the forfeiture, whether or not the Grantee accepts the Company&#146;s tender of payment for such Restricted Shares. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5 <U>Voting and Dividend Equivalent Rights Attributable to Restricted Shares</U>. A
Grantee awarded Restricted Shares will have all voting rights with respect to such Restricted Shares. Unless the Committee determines and sets forth in the Award Agreement that Grantee will not be entitled to receive any dividends with respect to
such Restricted Shares, a Grantee will have the right to receive all dividends in respect of such Restricted Shares, which dividends shall be either deemed reinvested in additional shares of Restricted Shares, which shall remain subject to the same
forfeiture conditions applicable to the Restricted Shares to which such dividends relate, or paid in cash if and at the time the Restricted Shares are no longer subject to forfeiture, as the Committee shall set forth in the Award Agreement. No
dividends may be paid with respect to Restricted Shares that are Forfeited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.6 <U>Escrow; Legends</U>. The Committee may provide that
the certificates for any Restricted Shares if certificated (x)&nbsp;shall be held (together with a stock transfer form executed in blank by the Grantee) in escrow by the Secretary of the Company until such Restricted Shares become <FONT
STYLE="white-space:nowrap">non-Forfeitable</FONT> or are Forfeited and/or (y)&nbsp;shall bear an appropriate legend restricting the transfer of such Restricted Shares under the Plan. If any Restricted Shares become nonforfeitable, the Company shall
cause certificates for such shares to be delivered without such legend. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 9 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Deferred Stock and Restricted Stock Units </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <U>Grant of Deferred Stock and Restricted Stock Units</U>. Subject to and consistent with the provisions of the Plan, the Committee, at
any time and from time to time, may grant Deferred Stock and/or Restricted Stock Units to any Eligible Person, in such amount and upon such terms as the Committee shall determine. Deferred Stock must conform in form and substance with applicable
regulations promulgated under Section&nbsp;409A of the Code and with Article 15 to ensure that the Grantee is not subjected to tax penalties under Section&nbsp;409A of the Code with respect to such Deferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <U>Vesting and Delivery</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Delivery of Shares subject to a Deferred Stock grant will occur upon expiration of the deferral period or upon the
occurrence of one or more of the distribution events described in Section&nbsp;409A of the Code as specified by the Committee in the Grantee&#146;s Award Agreement for the Award of Deferred Stock. An Award of Deferred Stock may be subject to such
substantial risk of forfeiture conditions as the Committee may impose, which conditions may lapse at such times or upon the achievement of such objectives as the Committee shall determine at the time of grant or thereafter. Unless otherwise
determined by the Committee, to the extent that the Grantee has a Termination of Service while the Deferred Stock remains subject to a substantial risk of forfeiture, such Deferred Shares shall be forfeited, unless the Committee determines that such
substantial risk of forfeiture shall lapse in the event of the Grantee&#146;s Termination of Service due to Retirement, death, Disability, or involuntary termination by the Company or an Affiliate without &#147;Cause.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Delivery of Shares subject to a grant of Restricted Stock Units shall occur no later than the 15th day of the third month
following the end of the taxable year of the Grantee or the fiscal year of the Company in which the Grantee&#146;s rights under such Restricted Stock Units are no longer subject to a substantial risk of forfeiture as defined in final regulations
under Section&nbsp;409A of the Code. Unless otherwise determined by the Committee, to the extent that the Grantee has a Termination of Service while the Restricted Stock Units remain subject to a substantial risk of forfeiture, such Restricted Stock
Units shall be forfeited, unless the Committee determines that such substantial risk of forfeiture shall lapse in the event of the Grantee&#146;s Termination of Service due to Retirement, death, Disability, or involuntary termination by the Company
or an Affiliate without Cause or termination by the Grantee for Good Reason. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <U>Voting and Dividend Equivalent Rights Attributable to Deferred Stock and Restricted
Stock Units</U>. A Grantee awarded Deferred Stock or Restricted Stock Units will have no voting rights with respect to such Deferred Stock or Restricted Stock Units prior to the delivery of Shares in settlement of such Deferred Stock and/or
Restricted Stock Units. Unless the Committee determines and sets forth in the Award Agreement that a Grantee will not be entitled to receive any such Dividend Equivalents with respect to such Deferred Stock or Restricted Stock Units, the Grantee
will have the right to receive Dividend Equivalents in respect of Deferred Stock and/or Restricted Stock Units, which Dividend Equivalents shall be either deemed reinvested in additional Shares of Deferred Stock or Restricted Stock Units, as
applicable, which shall remain subject to the same forfeiture conditions applicable to the Deferred Stock or Restricted Stock Units to which such Dividend Equivalents relate, or paid in cash if and at the time the Deferred Stock or Restricted Stock
Units are no longer subject to forfeiture and deliverable, as the Committee shall set forth in the Award Agreement. No Dividend Equivalents may be paid on Deferred Stock or Restricted Stock Units that are Forfeited. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 10 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Performance
Units and Performance Shares </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1 <U>Grant of Performance Units and Performance Shares</U>. Subject to and consistent with the
provisions of the Plan, Performance Units or Performance Shares may be granted to any Eligible Person in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2 <U>Value/Performance Goals</U>. The Committee shall set Performance Measures in its discretion which, depending on the extent to which
they are met, will determine the number or value of Performance Units or Performance Shares that will be paid to the Grantee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3
<U>Earning of Performance Units and Performance Shares</U>. After the applicable Performance Period has ended, the holder of Performance Units or Performance Shares shall be entitled to payment based on the level of achievement of performance goals
set by the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the discretion of the Committee, the settlement of Performance Units or Performance Shares may be in cash,
Shares of equivalent value, or in some combination thereof, as set forth in the Award Agreement provided that if it is to be in Shares, issuance of the Shares shall be subject to payment by the Grantee in cash of the nominal value for each Share so
issued to the extent required by Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Grantee is promoted, demoted or transferred to a different business unit of the
Company during a Performance Period, then, to the extent the Committee determines that the Award, the performance goals, or the Performance Period are no longer appropriate, the Committee may adjust, change, eliminate or cancel the Award, the
performance goals, or the applicable Performance Period, as it deems appropriate in order to make them appropriate and comparable to the initial Award, the performance goals, or the Performance Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Committee determines and sets forth in the Award Agreement that a Grantee will not be entitled to vote or receive any dividends or
Dividend Equivalents declared with respect to Shares deliverable in connection with grants of Performance Units or Performance Shares, the Grantee shall have the right to vote the Shares in respect of such Performance Shares and the right to receive
any dividends or Dividend Equivalents in respect of such Performance Units and Performance Shares, which dividends and Dividend Equivalents shall either be deemed reinvested in additional Shares of Performance Units or Performance Shares, as
applicable, which shall remain subject to the same forfeiture conditions applicable to the Performance Units or Performance Shares to which such dividends and Dividend Equivalents relate, or paid in cash if and at the time the Performance Units or
Performance Shares are payable and/or no longer subject to forfeiture, as the Committee shall set forth in the Award Agreement. No dividends or Dividend Equivalents may be paid on Performance Units or Performance Shares that are forfeited. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 11 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dividend Equivalents </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Committee is authorized to grant Awards of Dividend Equivalents alone or in conjunction with other Awards; provided, however, that no Dividend Equivalents may be granted in conjunction with any grant of Options or SARs, and no Dividend Equivalents
may be paid on any Awards other than Options and SARs unless and until the Awards become vested, nonforfeitable and/or payable. The Committee may provide that Dividend Equivalents not paid in connection with an Award shall either be (i)&nbsp;paid or
distributed in cash when the Dividend Equivalents or Awards to which such Dividend Equivalents relate become vested, nonforfeitable and/or payable or (ii)&nbsp;deemed to have been reinvested in additional Dividends Equivalents or Awards. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 12 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Other
Stock-Based Awards </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Committee is authorized, subject to limitations under Applicable Law, to grant such other Awards that are
denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Shares, as deemed by the Committee to be consistent with the purposes of the Plan, including Shares awarded which are not subject to any
restrictions or conditions, convertible or exchangeable debt securities or other rights convertible or exchangeable into Shares, and Awards valued by reference to the value of securities of or the performance of specified Affiliates. Subject to and
consistent with the provisions of the Plan, the Committee shall determine the terms and conditions of such Awards. Except as provided by the Committee, Shares delivered pursuant to a purchase right granted under this Article 12 shall be purchased
for such consideration, paid for by such methods and in such forms, including cash, Shares, outstanding Awards or other property, as the Committee shall determine. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 13 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director Awards </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms of the Plan, the Committee may grant Awards to
any <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director, in such amount and upon such terms and at any time and from time to time as shall be determined by the Committee in its sole discretion. Except as otherwise provided in
Section&nbsp;5.6(b), a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director may not be granted Awards during any single calendar year that, taken together with any cash fees paid to such <FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Director during such calendar year in respect of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s service as a member of the Board during such year, exceeds $1,250,000 in total value (calculating the value of any such Awards
based on the grant date fair value of such Awards for financial accounting purposes). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 14 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amendment, Modification, and Termination </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.1 <U>Amendment, Modification, and Termination</U>. Subject to Section&nbsp;14.2, the Board may, at any time and from time to time, alter,
amend, suspend, discontinue or terminate the Plan in whole or in part without the approval of the Company&#146;s stockholders, except that (a)&nbsp;any amendment or alteration shall be subject to the approval of the Company&#146;s stockholders if
such stockholder approval is required by any Applicable Law, and (b)&nbsp;the Board may otherwise, in its discretion, determine to submit other such amendments or alterations to stockholders for approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.2 <U>Awards Previously Granted</U>. Except as otherwise specifically permitted in the
Plan or an Award Agreement, no termination, amendment, or modification of the Plan shall adversely affect in any material way any Award previously granted under the Plan, without the written consent of the Grantee of such Award. Notwithstanding the
foregoing, the Board reserves the authority to terminate a 409A Award granted under the Plan in return for payment of the vested portion of the 409A Award provided the termination and payment satisfies the rules under Section&nbsp;409A of the Code.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 15 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Compliance with Code Section&nbsp;409A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.1 <U>Awards Subject to Code Section</U><U></U><U>&nbsp;409A</U>. The provisions of this Article 15 and Section&nbsp;409A of the Code shall
apply to any Award or portion thereof that is or becomes deferred compensation subject to Code Section&nbsp;409A (a &#147;<U>409A Award</U>&#148;), notwithstanding any provision to the contrary contained in the Plan or the Award Agreement applicable
to such Award to the extent required for the Award to comply with Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.2 <U>Distributions</U>. Except as
otherwise permitted or required by Code Section&nbsp;409A, no distribution in settlement of a 409A Award may commence earlier than (i)&nbsp;Separation from Service; (ii)&nbsp;the date the Grantee becomes Disabled (as defined in
Section&nbsp;2.26(b)); (iii) the date of the Grantee&#146;s death; (iv)&nbsp;a specified time (or pursuant to a fixed schedule) that is either (a)&nbsp;specified by the Committee upon the grant of the Award and set forth in the Award Agreement or
(b)&nbsp;specified by the Grantee in an Election complying with the requirements of Section&nbsp;409A of the Code; or (vi)&nbsp;a change in control of the Company within the meaning of Treasury Regulation
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(h)(5).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.3 <U>Six Month Delay</U>. Notwithstanding anything herein or in
any Award Agreement or election to the contrary, to the extent that distribution of a 409A Award is triggered by a Grantee&#146;s Separation from Service, if the Grantee is then a &#147;specified employee&#148; (as defined in Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-1(i)),</FONT> no distribution may be made before the date which is six (6)&nbsp;months after such Grantee&#146;s Separation from Service, or, if earlier, the date of the Grantee&#146;s death, to the
extent required to comply with Code Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.4 <U>Short-Term Deferral</U>. If an Award Agreement does not specify a payment
date, payment of the Award will be made no later than the 15th day of the third month following the end of the taxable year of the Grantee during which the Grantee&#146;s right to payment is no longer subject to a substantial risk of forfeiture
under Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Withholding </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.1
<U>Required Withholding</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Committee in its sole discretion may provide that when taxes are to be withheld in
connection with the exercise of an Option or SAR, or upon the lapse of restrictions on Restricted Shares, or upon the transfer of Shares, or upon payment of any other benefit or right under this Plan (the date on which such exercise occurs or such
restrictions lapse or such payment of any other benefit or right occurs hereinafter referred to as the &#147;<U>Tax Date</U>&#148;), the Grantee may elect to make payment for the withholding of federal, state and local taxes, including Social
Security and Medicare (&#147;<U>FICA</U>&#148;) taxes by one or a combination of the following methods: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) payment of an amount in cash equal to the amount to be withheld
(including cash obtained through the sale of the Shares acquired on exercise of an Option or SAR, upon the lapse of restrictions on Restricted Shares, or upon the transfer of Shares, through a broker-dealer to whom the Grantee has submitted
irrevocable instructions to deliver promptly to the Company, the amount to be withheld); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) delivering part or all of
the amount to be withheld in the form of Shares valued at their Fair Market Value on the Tax Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) requesting the
Company to withhold from those Shares that would otherwise be received upon exercise of the Option or SAR, upon the lapse of restrictions on Restricted Stock, or upon the transfer of Shares, a number of Shares having a Fair Market Value on the Tax
Date equal to the amount to be withheld; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) withholding from any other compensation otherwise due to the Grantee.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Committee in its sole discretion may provide that the maximum amount of tax withholding upon exercise of an Option or
SAR, upon the lapse of restrictions on Restricted Shares, or upon the transfer of Shares, to be satisfied by withholding Shares upon exercise of such Option or SAR, upon the lapse of restrictions on Restricted Shares, or upon the transfer of Shares,
pursuant to clause (iii)&nbsp;above shall not exceed the minimum amount of taxes, including FICA taxes, required to be withheld under federal, state and local law that will not result in adverse financial accounting consequences with respect to such
Awards and is permitted under applicable withholding rules promulgated by the Internal Revenue Service or another applicable governmental entity. An election by Grantee under this subsection is irrevocable. Any fractional share amount and any
additional withholding not paid by the withholding or surrender of Shares must be paid in cash. If no timely election is made, the Grantee must deliver cash to satisfy all tax withholding requirements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, any Grantee who makes a Disqualifying Disposition or an election under Section&nbsp;83(b) of
the Code shall remit to the Company an amount, if any, sufficient to satisfy all resulting tax withholding requirements in the same manner as set forth in subsection (a) (other than (a)(iii) above). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.2 <U>Notification under Code Section</U><U></U><U>&nbsp;83(b)</U>. If the Grantee, in connection with the exercise of any Option, or the
grant of Restricted Shares, makes the election permitted under Section&nbsp;83(b) of the Code to include in such Grantee&#146;s gross income in the year of transfer the amounts specified in Section&nbsp;83(b) of the Code, then such Grantee shall
notify the Company of such election within 10 days of filing the notice of the election with the Internal Revenue Service, in addition to any filing and notification required pursuant to regulations issued under Section&nbsp;83(b) of the Code. The
Committee may, in connection with the grant of an Award or at any time thereafter, prohibit a Grantee from making the election described above. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 17 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Limitation
on Benefits </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Despite any other provisions of this Plan to the contrary, if the receipt of any payments or benefits under this Plan,
alone or in combination with any other payments or distributions under any other plan, agreement or arrangement, would subject a Grantee to tax under Code Section&nbsp;4999, the Committee may determine whether some amount of such payments or
benefits would meet the definition of a &#147;Reduced Amount.&#148; If the Committee determines that there is a Reduced Amount, the total payments or benefits to the Grantee under all Awards must be reduced to such Reduced Amount, but not below
zero, with the amounts to be reduced so as to maximize the aggregate Net After Tax Receipts to the Grantee; provided, that, notwithstanding the foregoing, payments or benefits that are not subject to Section&nbsp;409A of the Code
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall be reduced before any payment or benefits that are subject to Section&nbsp;409A of the Code and all such reductions shall comply with Section&nbsp;409A of the Code with respect to any
amounts subject to Section&nbsp;409A of the Code. If the Committee determines that the benefits and payments must be reduced to the Reduced Amount, the Company must promptly notify the Grantee of that determination, with a copy of the detailed
calculations by the Committee. All determinations of the Committee under this Article 17 are final, conclusive and binding upon the Company and the Grantee. It is the intention of the Company and the Grantee to reduce the payments under this Plan
only if the aggregate Net After Tax Receipts to the Grantee would thereby be increased. As result of the uncertainty in the application of Code Section&nbsp;4999 at the time of the initial determination by the Committee under this Article 17,
however, it is possible that amounts will have been paid under the Plan to or for the benefit of a Grantee which should not have been so paid (&#147;<U>Overpayment</U>&#148;) or that additional amounts which will not have been paid under the Plan to
or for the benefit of a Grantee could have been so paid (&#147;<U>Underpayment</U>&#148;), in each case consistent with the calculation of the Reduced Amount. If the Committee, based either upon the assertion of a deficiency by the Internal Revenue
Service against the Company or the Grantee, which the Committee believes has a high probability of success, or controlling precedent or other substantial authority, determines that an Overpayment has been made, any such Overpayment must be treated
for all purposes as a loan, to the extent permitted by Applicable Law, which the Grantee must repay to the Company together with interest at the applicable federal rate under Code Section&nbsp;7872(f)(2); provided, however, that no such loan may be
deemed to have been made and no amount shall be payable by the Grantee to the Company if and to the extent such deemed loan and payment would not either reduce the amount on which the Grantee is subject to tax under Code Section&nbsp;1, 3101 or 4999
or generate a refund of such taxes. If the Committee, based upon controlling precedent or other substantial authority, determines that an Underpayment has occurred, the Committee must promptly notify the Company of the amount of the Underpayment,
which then shall be paid promptly to the Grantee but no later than the end of the Grantee&#146;s taxable year next following the Grantee&#146;s taxable year in which the determination is made that the underpayment has occurred. For purposes of this
Article 17, (i) &#147;<U>Net After Tax Receipt</U>&#148; means the Present Value of payments and benefits under this Plan and any other plan, agreement or arrangement, net of all taxes imposed on Grantee with respect thereto under Code Sections 1,
3101 and 4999, determined by applying the highest marginal rate under Code Section&nbsp;1 which applies to the Grantee&#146;s taxable income for the applicable taxable year; (ii) &#147;<U>Present Value</U>&#148; means the value determined in
accordance with Code Section&nbsp;280G(d)(4) and (iii) &#147;<U>Reduced Amount</U>&#148; means the smallest aggregate amount of all payments and benefits under this Plan and any other plan, agreement or arrangement, which (a)&nbsp;is less than the
sum of all such payments and benefits under this Plan and any other plan, agreement or arrangement, and (b)&nbsp;results in aggregate Net After Tax Receipts which are equal to or greater than the Net After Tax Receipts which would result if the
aggregate payments and benefits under this Plan and any other plan, agreement or arrangement, were any other amount less than the sum of all payments and benefits to be made under this Plan. Any reduction of payments or benefits pursuant to this
Article 17 shall be made in the following order (first against any such items that are not subject to Section&nbsp;409A of the Code): (i) first against any cash compensation in order of the latest amounts to be paid and otherwise on a pro rata
basis, (ii)&nbsp;second against any benefits otherwise payable in order of the latest amounts to be delivered and otherwise on a pro rata basis; and (iii)&nbsp;third against any equity or related awards in order of the latest amounts to be settled
and otherwise on a pro rata basis. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 18 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Additional Provisions </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.1 <U>Successors</U>. All obligations of the Company under the Plan with respect to Awards granted hereunder shall be binding on any
successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise of all or substantially all of the business and/or assets of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.2 <U>Severability</U>. If any part of the Plan is declared by any court or governmental
authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any other part of the Plan. Any Section or part of a Section so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give
effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.3
<U>Requirements of Law</U>. The granting of Awards and the delivery of Shares under the Plan shall be subject to all Applicable Laws, rules, and regulations, and to such approvals by any governmental agencies or Nasdaq and any other stock exchange
or automated quotation system upon which the Shares are listed or quoted as may be required. Notwithstanding any provision of the Plan or any Award, Grantees shall not be entitled to exercise, or receive benefits under, any Award, and the Company
(and any Affiliate) shall not be obligated to deliver any Shares or deliver benefits to a Grantee, if such exercise or delivery would constitute a violation by the Grantee or the Company of any Applicable Law or regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.4 <U>Securities Law Compliance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If the Committee deems it necessary to comply with any Applicable Law, the Committee may impose any restriction on Awards
or Shares acquired pursuant to Awards under the Plan as it may deem advisable. In addition, if requested by the Company and any underwriter engaged by the Company, Shares acquired pursuant to Awards may not be sold or otherwise transferred or
disposed of for such period following the date of the final prospectus or prospectus supplement relating to an underwritten public offering as the Company or such underwriter shall specify reasonably and in good faith. All certificates for Shares
delivered under the Plan pursuant to any Award or the exercise thereof shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations and other requirements of the SEC, Nasdaq
and any other stock exchange or automated quotation system upon which the Shares are listed or quoted, any applicable securities law, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to
such restrictions. If so requested by the Company, the Grantee shall make a written representation to the Company that he or she will not sell or offer to sell any Shares unless a registration statement shall be in effect with respect to such Shares
under the Securities Act and any applicable state securities law or unless he or she shall have furnished to the Company, in form and substance satisfactory to the Company, that such registration is not required. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If the Committee determines that the exercise or non-forfeitability of, or delivery of benefits pursuant to, any Award
would violate any Applicable Law or result in the imposition of excise taxes on the Company or its Affiliates under the statutes, rules or regulations of any applicable jurisdiction, then the Committee may postpone any such exercise,
non-forfeitability or delivery, as applicable, but the Company shall use all reasonable efforts to cause such exercise, non-forfeitability or delivery to comply with all such provisions at the earliest practicable date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Committee may require each Grantee receiving Shares pursuant to an Award under the Plan to represent to and agree with
the Company in writing that the Grantee is acquiring the Shares without a view to distribution thereof. In addition to any legend required by the Plan, the certificates for such Shares may include any legend that the Committee deems appropriate to
reflect any restrictions on transfer. All certificates for Shares delivered under the Plan shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations and other requirements
of the SEC, Nasdaq and any other stock exchange or automated quotation system upon which the Shares are listed or quoted, any applicable federal or state securities law, and any applicable corporate law, and the Committee may cause a legend or
legends to be put on any such certificates to make appropriate reference to such restrictions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) A Grantee shall be required to supply the Company with certificates,
representations and information that the Company requests and otherwise cooperate with the Company in obtaining any listing, registration, qualification, exemption, consent or approval the Company deems necessary or appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.5 <U>Awards Subject to Share Retention Guidelines and Claw-Back Policies</U>. Notwithstanding any provisions herein to the contrary,
(i)&nbsp;Shares acquired by a Grantee under the Plan upon the exercise, payment or settlement of an Award shall be subject to the terms of any Share retention guidelines currently in effect or subsequently adopted by the Board and (ii)&nbsp;all
Awards granted hereunder shall be subject to the terms of any recoupment policy currently in effect or subsequently adopted by the Board to implement Section&nbsp;304 of Sarbanes-Oxley, Dodd-Frank or Section&nbsp;10D of the Exchange Act (or with any
amendment or modification of such recoupment policy adopted by the Board) to the extent that such Award (whether or not previously exercised or settled) or the value of such Award is required to be returned to the Company pursuant to the terms of
such recoupment policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.6 <U>No Rights as a Stockholder</U>. Unless otherwise determined by the Committee and set forth in the Award
Agreement, no Grantee shall have any rights as a stockholder of the Company with respect to the Shares (other than Restricted Shares) which may be deliverable upon exercise or payment of such Award until such Shares have been delivered to him or
her. Restricted Shares, whether held by a Grantee or in escrow by the Secretary of the Company, shall confer on the Grantee all rights of a stockholder of the Company, except as otherwise provided in the Plan or Award Agreement. At the time of grant
of an Award, the Committee will require the payment of cash dividends thereon to be deferred and, if the Committee so determines, reinvested in additional Awards. Stock dividends and deferred cash dividends issued with respect to Awards shall be
subject to the same restrictions and other terms as apply to the Awards with respect to which such dividends are issued. The Committee may in its discretion provide for payment of interest on deferred cash dividends. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.7 <U>Employee Status</U>. If the terms of any Award provide that it may be exercised or paid only during employment or continued service or
within a specified period of time after termination of employment or continued service, the Committee may decide to what extent leaves of absence for governmental or military service, illness, temporary disability, or other reasons shall not be
deemed interruptions of continuous employment or service. For purposes of the Plan, employment and continued service shall be deemed to exist between the Grantee and the Company and/or an Affiliate if, at the time of the determination, the Grantee
is a director, officer, employee, consultant or advisor of the Company or an Affiliate. A Grantee on military leave, sick leave or other bona fide leave of absence shall continue to be considered an employee for purposes of the Plan during such
leave if the period of leave does not exceed three months, or, if longer, so long as the individual&#146;s right to <FONT STYLE="white-space:nowrap">re-employment</FONT> with the Company or any of its Affiliates is guaranteed either by statute,
agreement or contract. If the period of leave exceeds three months, and the individual&#146;s right to <FONT STYLE="white-space:nowrap">re-employment</FONT> is not guaranteed by statute, agreement or contract, the employment shall be deemed to be
terminated on the first day after the end of such three-month period. Except as may otherwise be expressly provided in an Agreement, Awards granted to a director, officer, employee, consultant or adviser shall not be affected by any change in the
status of the Grantee so long as the Grantee continues to be a director, officer, employee, consultant or advisor to the Company or any of its Affiliates (regardless of having changed from one to the other or having been transferred from one entity
to another). The Grantee&#146;s employment or continued service shall not be considered interrupted in the event the Committee, in its discretion and as specified at or prior to such occurrence, determines there is no interruption in the case of a <FONT
STYLE="white-space:nowrap">spin-off,</FONT> sale or disposition of the Grantee&#146;s employer from the Company or an Affiliate, except that if the Committee does not otherwise specify such at or prior to such occurrence,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Grantee will be deemed to have a termination of employment or continuous service to the extent the Affiliate that employs the Grantee is no longer the Company or an entity that qualifies as
an Affiliate. With respect to any Award constituting deferred compensation with the meaning of Code Section&nbsp;409A, nothing in this Section&nbsp;18.7 shall be interpreted to modify the definition of Separation from Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.8 <U>Nature of Payments</U>. Unless otherwise specified in the Award Agreement, Awards shall be special incentive payments to the Grantee
and shall not be taken into account in computing the amount of salary or compensation of the Grantee for purposes of determining any pension, retirement, death or other benefit under (a)&nbsp;any pension, retirement, profit sharing, bonus, insurance
or other employee benefit plan of the Company or any Affiliate, except as such plan shall otherwise expressly provide, or (b)&nbsp;any agreement between (i)&nbsp;the Company or any Affiliate and (ii)&nbsp;the Grantee, except as such agreement shall
otherwise expressly provide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.9 <U><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Plan</U>. Neither the adoption of the
Plan by the Board nor its submission to the stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board to adopt such other compensatory arrangements for employees or <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Directors as it may deem desirable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.10 <U>Governing Law</U>. The Plan, and all
agreements hereunder, shall be construed in accordance with and governed by the laws of the State of South Carolina, other than its laws respecting choice of law, to the extent not preempted by federal law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.11 <U>Jurisdiction; Waiver of Jury Trial</U>. Any suit, action or proceeding with respect to the Plan or any Award, or any judgment entered
by any court of competent jurisdiction in respect of any thereof, shall be resolved only in the courts of the State of South Carolina or the United States District Court for the State of South Carolina and the appellate courts having jurisdiction of
appeals in such courts. In that context, and without limiting the generality of the foregoing, the Company and each Grantee shall irrevocably and unconditionally (a)&nbsp;submit in any proceeding relating to the Plan or any Award Agreement, or for
the recognition and enforcement of any judgment in respect thereof (a &#147;<U>Proceeding</U>&#148;), to the exclusive jurisdiction of the courts of the State of South Carolina, the court of the United States of America for the State of South
Carolina, and appellate courts having jurisdiction of appeals from any of the foregoing, and agree that all claims in respect of any such Proceeding shall be heard and determined in such South Carolina State court or, to the extent permitted by law,
in such federal court, (b)&nbsp;consent that any such Proceeding may and shall be brought in such courts and waives any objection that the Company and each Grantee may now or thereafter have to the venue or jurisdiction of any such Proceeding in any
such court or that such Proceeding was brought in an inconvenient court and agree not to plead or claim the same, (c)&nbsp;waive all right to trial by jury in any Proceeding (whether based on contract, tort or otherwise) arising out of or relating
to the Plan or any Award Agreement, (d)&nbsp;agree that service of process in any such Proceeding may be effected by mailing a copy of such process by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such
party, in the case of a Grantee, at the Grantee&#146;s address shown in the books and records of the Company or, in the case of the Company, at the Company&#146;s principal offices, attention General Counsel, and (e)&nbsp;agree that nothing in the
Plan shall affect the right to effect service of process in any other manner permitted by the laws of the State of South Carolina. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.12
<U>Unfunded Status of Awards; Creation of Trusts</U>. The Plan is intended to constitute an &#147;unfunded&#148; plan for incentive and deferred compensation. With respect to any payments not yet made to a Grantee pursuant to an Award, nothing
contained in the Plan or any Award Agreement shall give any such Grantee any rights that are greater than those of a general creditor of the Company; provided, however, that the Committee may authorize the creation of trusts or make other
arrangements to meet the Company&#146;s obligations under the Plan to deliver cash, Shares or other property pursuant to any Award which trusts or other arrangements shall be consistent with the &#147;unfunded&#148; status of the Plan unless the
Committee otherwise determines. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.13 <U>Participation</U>. No employee or officer shall have the right to be selected to
receive an Award under this Plan or, having been so selected, to be selected to receive a future Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.14 <U>Military Service</U>.
Awards shall be administered in accordance with Section&nbsp;414(u) of the Code and the Uniformed Services Employment and Reemployment Rights Act of 1994. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.15 <U>Construction</U>. The following rules of construction will apply to the Plan: (a)&nbsp;the word &#147;or&#148; is disjunctive but not
necessarily exclusive, and (b)&nbsp;words in the singular include the plural and words in the plural include the singular. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.16 <U>Other
Benefits</U>. No Award granted or paid out under the Plan shall be deemed compensation for purposes of computing benefits under any retirement plan of the Company or its Affiliates nor affect any benefit under any other benefit plan now or
subsequently in effect under which the availability or amount of benefits is related to the level of compensation unless such retirement or other benefit specifically provides that an Award shall be counted as compensation for purposes of such plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.17 <U>Death/Disability</U>. The Committee may in its discretion require the transferee of a Grantee to supply it with written notice
of the Grantee&#146;s death or Disability and to supply it with a copy of the will (in the case of the Grantee&#146;s death) or such other evidence as the Committee deems necessary to establish the validity of the transfer of an Award. The Committee
may also require that the agreement of the transferee to be bound by all of the terms and conditions of the Plan and the particular Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.18 <U>Headings</U>. The headings of articles and sections are included solely for convenience of reference, and if there is any conflict
between such headings and the text of this Plan, the text shall control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.19 <U>Obligations</U>. Unless otherwise specified in the
Award Agreement, the obligation to deliver, pay or transfer any amount of money or other property pursuant to Awards under this Plan shall be the sole obligation of a Grantee&#146;s employer; provided that the obligation to deliver or transfer any
Shares pursuant to Awards under this Plan shall be the sole obligation of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.20 <U>No Right to Continue in Service or
Employment</U>. Nothing in the Plan or any Award Agreement shall confer upon any <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director the right to continue to serve as a director of the Company. Nothing contained in the Plan or any
Agreement shall confer upon any Grantee any right with respect to the continuation of employment or service by the Company or any Affiliate or interfere in any way with the right of the Company or any Affiliate, subject to the terms of any separate
employment agreement to the contrary, at any time to terminate such employment or service or to increase or decrease the compensation of the Grantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.21 <U>Payment on Behalf of Grantee or Beneficiary</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If the Grantee is incompetent to handle Grantee&#146;s affairs at the time the Grantee is eligible to receive a payment
from the Plan, the Committee will make payment to the Grantee&#146;s court-appointed personal representative or, if none, the Committee, in its sole discretion, may make payment to the Grantee&#146;s duly appointed guardian, legal representative, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">next-of-kin</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> for the benefit of the Grantee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If the Beneficiary of a deceased Grantee is a minor or is legally
incompetent, the Committee will make payment to the Beneficiary&#146;s court-appointed guardian or personal representative or to a trust established for the benefit of the Beneficiary, or if no such guardian, representative or trust exists, the
Committee, in its sole discretion, may make payment to the Beneficiary&#146;s surviving parent or his or her <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">next-of-kin</FONT></FONT> for the benefit of the Beneficiary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If the Committee for any reason considers it improper to direct any payment as specified in this Section&nbsp;18.21, the
Committee may request a court of appropriate jurisdiction to determine the appropriate payee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Any payment made by the
Committee pursuant to this Section&nbsp;18.21 shall be in full satisfaction of all liability of the Plan, the Company and its Affiliates with respect to any benefit due a Grantee or a Grantee&#146;s Beneficiary under this Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.22 <U>Data Privacy</U>. As a condition for receiving an Award, each Grantee explicitly and unambiguously consents to the collection, use
and transfer, in electronic or other form, of personal data as described in this Section by and among the Company and its Affiliates exclusively for implementing, administering and managing the Grantee&#146;s participation in the Plan. The Company
and its Affiliates may hold certain personal information about a Grantee, including the Grantee&#146;s name, address and telephone number; birthdate; social security, insurance number or other identification number; salary; nationality; job
title(s); any Shares held in the Company or its Affiliates; and Award details, to implement, manage and administer the Plan and Awards (the &#147;<U>Data</U>&#148;). The Company and its Affiliates may transfer the Data amongst themselves as
necessary to implement, administer and manage a Grantee&#146;s participation in the Plan, and the Company and its Affiliates may transfer the Data to third parties assisting the Company with Plan implementation, administration and management. These
recipients may be located in the Grantee&#146;s country, or elsewhere, and the Grantee&#146;s country may have different data privacy laws and protections than the recipients&#146; country. By accepting an Award, each Grantee authorizes such
recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, to implement, administer and manage the Grantee&#146;s participation in the Plan, including any required Data transfer to a broker or other third party
with whom the Company or the Grantee may elect to deposit any Shares. The Data related to a Grantee will be held only as long as necessary to implement, administer, and manage the Grantee&#146;s participation in the Plan. A Grantee may, at any time,
view the Data that the Company holds regarding such Grantee, request additional information about the storage and processing of the Data regarding such Grantee, recommend any necessary corrections to the Data regarding the Grantee or refuse or
withdraw the consents in this Section&nbsp;18.22 in writing, without cost, by contacting the local human resources representative. The Company may cancel Grantee&#146;s ability to participate in the Plan and, in the Committee&#146;s discretion, the
Grantee may forfeit any outstanding Awards if the Grantee refuses or withdraws the consents in this Section&nbsp;18.22. For more information on the consequences of refusing or withdrawing consent, Grantees may contact their local human resources
representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.23 <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) No person shall have any claim or right to receive an Award hereunder. The Committee&#146;s granting of an Award to a
Grantee at any time shall neither require the Committee to grant any other Award to such Grantee or other person at any time or preclude the Committee from making subsequent grants to such Grantee or any other person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Nothing contained herein prohibits the Grantee from: (1)&nbsp;reporting possible violations of federal law or regulations,
including any possible securities laws violations, to any governmental agency or entity; (2)&nbsp;making any other disclosures that are protected under the whistleblower provisions of federal law or regulations; or (3)&nbsp;otherwise fully
participating in any federal whistleblower programs, including but not limited to any such programs managed by the SEC. The Grantee does not need prior authorization from the Company to make any such reports or disclosures, and is not required to
notify the Company about such disclosures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Agreements evidencing Awards under the Plan shall contain such other
terms and conditions, not inconsistent with the Plan, as the Committee may determine in its sole discretion, including penalties for the commission of competitive acts or other actions detrimental to the Company. Notwithstanding any other provision
hereof, the Committee shall have the right at any time to deny or delay a Grantee&#146;s exercise of Options or the settlement of an Award if such Grantee is reasonably believed by the Committee (i)&nbsp;to be engaged in material conduct adversely
affecting the Company or (ii)&nbsp;to be contemplating such conduct, unless and until the Committee shall have received reasonable assurance that the Grantee is not engaged in, and is not contemplating, such material conduct adverse to the interests
of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Grantees are and at all times shall remain subject to the securities trading policies adopted by the
Company from time to time throughout the period of time during which they may exercise Options, SARs or sell Shares acquired pursuant to the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding any other provision of this Plan, (i)&nbsp;the Company shall not be obliged to issue any shares pursuant to
an Award unless at least the par value of such newly issued share has been fully paid in advance to the extent required by Applicable Law (which requirement may mean the holder of an Award is obliged to make such payment) and (ii)&nbsp;the Company
shall not be obliged to issue or deliver any shares in satisfaction of Awards until all legal and regulatory requirements associated with such issue or delivery have been complied with to the satisfaction of the Committee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The Committee has no obligation to search for the whereabouts of any Grantee or Beneficiary if the location of such Grantee
or Beneficiary are not made known to the Committee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding any other provision of the Plan or any Agreement
to the contrary, a Grantee shall forfeit any and all rights under an Award upon receipt of notice from the Company or an Affiliate that the Grantee will incur a Termination of Service by the Company or such Affiliate for Cause. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d900233dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF RESTRICTED STOCK UNIT AWARD CERTIFICATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Service-Based) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I><FONT
STYLE="white-space:nowrap">Non-transferable</FONT> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GRANT TO </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(the &#147;<U>Participant</U>&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by ScanSource, Inc. (the &#147;<U>Company</U>&#148;) of </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the right to acquire _______ shares of the Company&#146;s common stock (the &#147;Common Stock&#148;), no par value per share (the &#147;<U>Shares</U>&#148;)
pursuant to and subject to the provisions of the ScanSource, Inc. 2024 Omnibus Incentive Compensation Plan, as it may be amended and/or restated (the &#147;<U>Plan</U>&#148;), and to the terms and conditions set forth in this certificate (the
&#147;<U>Award Certificate</U>&#148;). The Award Certificate describes terms and conditions of the Restricted Stock Unit Award (the &#147;<U>Award</U>&#148;) granted herein and constitutes an agreement between the Participant and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless vesting is accelerated in accordance with the Plan or the Award Certificate, the vesting restrictions imposed under <U>Section</U><U></U><U>&nbsp;2</U>
of the Award Certificate will expire with respect to the Award and the underlying Shares of the Award ratably in ___ equal annual installments (__%-__%-__%-__%), commencing as of _______, 20__, provided that the Participant has been continuously
employed by the Company as of the date hereof (the &#147;<U>Grant Date</U>&#148;) until each respective vesting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, The Company
acting by and through its duly authorized officers, has caused the Award Certificate to be executed as of the Grant Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SCANSOURCE, INC. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Grant Date: ______ </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AWARD CERTIFICATE TERMS AND CONDITIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U>Grant of Award</U>. The Company hereby grants to the Participant, subject to the restrictions and the other terms and conditions set forth in the Plan
and the Award, the number of Shares indicated on Page 1 hereof of the Common Stock. For the purposes herein, the Shares subject to the Award are units that will be reflected in a book account maintained by the Company and that will be settled in
shares of Common Stock if and only to the extent permitted under the Plan and the Award Certificate. Prior to issuance of any underlying Shares upon vesting of the Award, the Award shall represent an unsecured obligation of the Company, payable (if
at all) only from the Company&#146;s general assets. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Restrictions; Forfeiture</U>. The Award and the underlying Shares are subject to the following restrictions. No right or interest of the Participant in
the Award, to the extent restricted, may be pledged, encumbered or hypothecated to or in favor of any party other than the Company or an Affiliate or shall be subject to any lien, obligation or liability of the Participant to any other party other
than the Company or an Affiliate. Except as otherwise provided in the Plan, the Award shall not be transferable (including by sale, assignment, pledge or hypothecation) other than by will or the laws of intestate succession. Prior to vesting, the
underlying Shares subject to the Award may not be sold, transferred, exchanged, assigned, pledged, hypothecated or otherwise encumbered. Except as may be otherwise provided in the Plan or the Award Certificate, if the Participant&#146;s employment
with the Company terminates for any reason (whether by the Company or the Participant and whether voluntary or involuntary) other than as set forth in paragraphs (b)&nbsp;or (c) of <U>Section</U><U></U><U>&nbsp;3</U> hereof, then the Participant
shall forfeit all of the Participant&#146;s right, title and interest in and to the Award and the Shares to the extent the Award (and corresponding Shares) are not vested as of the date the Participant&#146;s Termination of Service. The restrictions
imposed under this section shall apply to all Shares or other securities issued with respect to Shares hereunder in connection with any merger, reorganization, consolidation, recapitalization, stock dividend or other change in corporate structure
affecting the Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Expiration and Termination of Restrictions</U>. The restrictions imposed under <U>Section</U><U></U><U>&nbsp;2</U> will
expire on the earliest to occur of the following (the period prior to such expiration being referred to herein as the &#147;<U>Restricted Period</U>&#148;): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) With respect to such ratable portion of the Shares as is specified on page 1 hereof, on each of the ___ annual vesting installment dates as specified on
page 1 hereof, provided the Participant is still employed by the Company on each respective anniversary of the Grant Date and has been employed continuously since the Grant Date; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) As to all of the Shares, upon the termination of the Participant&#146;s employment (meaning a separation from service (as defined under Code
Section&nbsp;409A)) due to death, Disability or Retirement; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) As to all of the Shares, in the event of a Change in Control, as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) To the extent that the successor or surviving company in the Change in Control event does not assume or substitute for the Award (or in which the Company
is the ultimate parent corporation and does not continue the Award) on substantially similar terms or with substantially equivalent economic benefits (as determined by the Committee) as Awards outstanding under the Plan immediately prior to the
Change in Control event, any restrictions, including but not limited to the restriction period, applicable to the Award shall be deemed to have been met, and the Award shall become fully vested, earned and payable to the fullest extent of the
original grant of the Award, provided the Participant remains employed by the Company from the Grant Date until the time of the Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii)
Further, the Award will nonetheless become vested in full if the employment or service of the Participant is terminated by the Company or the Participant in contemplation of a Change in Control (whether or not the Change in Control is consummated)
or, in the event that the Award is substituted, assumed or continued as provided in <U>Section</U><U></U><U>&nbsp;3(c)(i)</U> herein, within one year after the effective date of a Change in Control, if such termination of employment or service
(A)&nbsp;is by the Company not for Cause or (B)&nbsp;is by the Participant for Good Reason. The employment or service of the Participant will be deemed to have been terminated in contemplation of a Change in Control if the Participant&#146;s
employment or service terminates at any time during which (i)&nbsp;the Company has initiated a transaction process or is engaged in discussions with a third party about a specific transaction that, if consummated, would result in a Change in Control
(and before complete abandonment of such discussions without the transaction being consummated) or (ii)&nbsp;the Company has become a party to a definitive agreement to consummate a transaction that would result in a Change in Control (and before
complete termination of such agreement without the transaction being consummated). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) For clarification, for the purposes of this
<U>Section</U><U></U><U>&nbsp;3</U>, &#147;Cause&#148; shall have the meaning given such term in <U>Section</U><U></U><U>&nbsp;2.15</U> of the Plan; &#147;Disability&#148; shall have the meaning given such term in
<U>Section</U><U></U><U>&nbsp;2.26(a)</U> of the Plan; &#147;Retirement&#148; shall have the meaning set forth in the Company&#146;s Executive Severance Plan, as it may be amended and/or restated, (the &#147;Executive Severance Plan&#148;);
<I>provided, however, that</I>, if on the Grant Date, the Participant is not a participant in the Executive Severance Plan, the meaning shall be the occurrence of both (i)&nbsp;the Participant&#146;s Termination of Service (other than for Cause) on
or after the date that Participant&#146;s age plus years of employment with the Company and its Affiliates equals or exceeds 65, and (ii)&nbsp;the Committee&#146;s determination that the Participant&#146;s termination qualifies as a retirement that
is not in connection with a pending involuntary termination, including any notification of inclusion in a reduction in force, and, provided that, if the Committee has not made a determination within thirty (30)&nbsp;days of the Participant&#146;s
Termination of Service, the Participant&#146;s termination shall be deemed to qualify as a retirement; and &#147;Good Reason&#148; shall have the same definition as under any employment, change in control or service agreement between the Company or
any Affiliate and the Participant or, if no such employment, change in control or service agreement exists or if such employment, change in control or service agreement does not contain any such definition, Good Reason shall mean, without the
Participant&#146;s consent, the following: (i)&nbsp;any action taken by the Company or an Affiliate which results in a material reduction in the Participant&#146;s authority, duties or responsibilities (except that any change in the foregoing that
results solely from (A)&nbsp;the Company ceasing to be a publicly traded entity or from the Company becoming a wholly-owned subsidiary of another publicly traded entity or (B)&nbsp;any change in the geographic scope of the Participant&#146;s
authority, duties or responsibilities will not, in any event and standing alone, constitute a substantial reduction in the Participant&#146;s authority, duties or responsibilities); (ii) the assignment to the Participant of duties that are
materially inconsistent with Participant&#146;s authority, duties or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
responsibilities; (iii)&nbsp;any material decrease in the Participant&#146;s base salary or annual bonus opportunity, except to the extent the Company has instituted a salary or bonus reduction
generally applicable to all similar employees of the Company other than in contemplation of or after a Change in Control; (iv)&nbsp;other than for international employees, the relocation of the Participant to any principal place of employment other
than that as of the date of grant of the Award, or any requirement that Participant relocate his or her residence other than to that as of the date of grant of the Award, without the Participant&#146;s express written consent to either such
relocation, which in either event would increase the Participant&#146;s commute by more than fifty (50)&nbsp;miles; provided, however, this subsection (iv)&nbsp;shall not apply in the case of business travel which requires the Participant to
relocate temporarily for periods of ninety (90)&nbsp;days or less; or (v)&nbsp;the failure by the Company to pay to the Participant any portion of the Participant&#146;s base salary or annual bonus within thirty (30)&nbsp;days after the date the
same is due. Notwithstanding the above, and without limitation, Good Reason shall not include any resignation by the Participant where Cause for the Participant&#146;s termination by the Company or an Affiliate exists. The Participant must give the
Company or Affiliate that employs the Participant notice of any event or condition that would constitute Good Reason within thirty (30)&nbsp;days of the event or condition which would constitute Good Reason, and, upon the receipt of such notice, the
Company or Affiliate that employs the Participant shall have thirty (30)&nbsp;days to remedy such event or condition. If such event or condition is not remedied within such thirty (30)&nbsp;day period, any termination of employment by the
Participant for Good Reason must occur within thirty (30)&nbsp;days after the period for remedying such condition or event has expired. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>Settlement
of Award; Delivery of Shares</U>. No certificate or certificates for the Shares shall be issued on the Grant Date. A certificate or certificates for the underlying Shares of the Award (or, in the case of uncertificated Shares, other written evidence
of ownership in accordance with applicable laws) shall be issued in the name of the Participant (or his beneficiary) only in the event, and to the extent, that the Award has vested. Notwithstanding the foregoing, the following provisions shall
apply: (a)&nbsp;except as provided under <U>Section</U><U></U><U>&nbsp;4(b)</U> herein or to the extent otherwise required or permitted under Code Section&nbsp;409A, any Shares or other benefits payable pursuant to the Award shall, upon vesting of
the Award, be distributed to the Participant (or his beneficiary) within sixty (60)&nbsp;days after the date the Award vests; and (b)&nbsp;in the event that the Restriction Period ends (and the Award vests) due to a separation from service (as
defined under Code Section&nbsp;409A) due to death, Disability or Retirement or in contemplation of a Change in Control or within one year after the effective date of the Change in Control, then the Shares shall be delivered to the Participant (or
his beneficiary) within sixty (60)&nbsp;days after the end of the Restriction Period (provided that if such sixty (60)&nbsp;day period begins in one (1)&nbsp;calendar year and ends in another, the Participant (or his beneficiaries) shall not have
the right to designate the calendar year of payment), and, provided, further, if the Participant is or may be a &#147;specified employee&#148; (as defined under Code Section&nbsp;409A), and the distribution is due to separation from service, then
such distribution shall be subject to delay as provided in <U>Section</U><U></U><U>&nbsp;15.3</U> of the Plan (or any successor provision thereto). Notwithstanding the foregoing or anything herein to the contrary, the Committee, in its sole
discretion and without the Participant&#146;s consent, retains the right to provide for settlement of this Award in cash, in lieu of delivery of Shares, as provided in <U>Section 3.2</U> of the Plan (or any successor provision thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U>Voting and Dividend Rights</U>. The Participant shall not be deemed to be the holder of any underlying Shares of the Award and shall not have any
dividend rights, voting rights or other rights as a shareholder unless and until (and only to the extent that) the Award has vested and certificates for such Shares have been issued to him (or, in the case of uncertificated shares, other written
evidence of ownership in accordance with applicable laws shall have been provided). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U>No Right of Continued Employment or to Future Awards</U>. Nothing in the Award Certificate shall
interfere with or limit in any way the right of the Company or any Affiliate to terminate the Participant&#146;s employment or service at any time, nor confer upon the Participant any right to continue in the employ or service of the Company or any
Affiliate. The grant of the Award does not create any obligation to grant further awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <U>Tax Matters</U>. The Participant will, no later than the
date as of which any amount related to the Shares first becomes includable in the Participant&#146;s gross income for federal income tax purposes, pay to the Company, or make other arrangements satisfactory to the Committee regarding payment of, any
federal, state, local and foreign taxes (including any Federal Insurance Contributions Act taxes) required by law to be withheld with respect to such amount. The withholding requirement may be satisfied, in whole or in part, unless the Committee
determines otherwise, by withholding from this Award Shares having a Fair Market Value on the date of withholding equal to the minimum amount (and not any greater amount) required to be withheld for tax purposes, all in accordance with such
procedures as the Committee establishes. The obligations of the Company under the Award Certificate will be conditional on such payment or arrangements, and the Company, or, where applicable, its Affiliates, will, to the extent permitted by law,
have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant. The Participant acknowledges that the Company has made no warranties or representations to the Participant with respect to the legal, tax or
investment consequences (including but not limited to income tax consequences) related to the grant of the Award or receipt or disposition of the Shares (or any other benefit), and the Participant is in no manner relying on the Company or its
representatives for legal, tax or investment advice related to the Award or the Shares. The Participant acknowledges that there may be adverse tax consequences upon the grant of the Award and/or the acquisition or disposition of the Shares (or other
benefit) subject to the Award and that the Participant has been advised to consult with their own attorney, accountant and/or tax advisor regarding the transactions contemplated by the Award and the Award Certificate. The Participant also
acknowledges that the Company has no responsibility to take or refrain from taking any actions in order to achieve a certain tax result for the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <U>Plan Controls; Entire Agreement; Amendment</U>. The terms contained in the Plan are incorporated into and made a part of the Award Certificate and the
Award Certificate shall be governed by and construed in accordance with the Plan. In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of the Award Certificate, the provisions of the Plan shall be
controlling and determinative (unless the Committee determines otherwise). The Award Certificate sets forth all of the promises, agreements, understandings, warranties and representations between the parties with respect to the Award. The Award
Certificate may be amended as provided in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. <U>Successors</U>. The Award Certificate shall be binding upon any successor of the Company, in
accordance with the terms of the Award Certificate and the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. <U>Severability</U>. If any one or more of the provisions contained in the Award
Certificate is held to be invalid, illegal or unenforceable, the other provisions of the Award Certificate will be construed and enforced as if the invalid, illegal or unenforceable provision had never been included. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. <U>Notice</U>. Notices and communications under the Award Certificate must be in writing and either
personally delivered or sent by registered or certified United States mail, return receipt requested, postage prepaid. Notices to the Company must be addressed to ScanSource, Inc., 6 Logue Court, Greenville, SC 29615, Attn: Secretary, or any other
address designated by the Company in a written notice to the Participant. Notices to the Participant will be directed to the address of the Participant then currently on file with the Company, or at any other address given by the Participant in a
written notice to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. <U>Beneficiary Designation</U>. The Participant may, in the manner determined by the Committee, designate a
beneficiary to exercise the rights of the Participant hereunder and to receive any distribution with respect to the Award upon the Participant&#146;s death. A beneficiary, legal guardian, legal representative, or other person claiming any rights
hereunder is subject to all terms and conditions of the Award Certificate and the Plan and to any additional restrictions deemed necessary or appropriate by the Committee. If no beneficiary has been designated or survives the Participant, the
Participant&#146;s rights with respect to the Award may be exercised by the legal representative of the Participant&#146;s estate, and payment shall be made to the Participant&#146;s estate. Subject to the foregoing, a beneficiary designation may be
changed or revoked by the Participant at any time provided the change or revocation is filed with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. <U>Compliance with Recoupment,
Ownership and Other Policies or Agreements</U>. As a condition to receiving the Award, the Participant agrees to abide by all provisions of any equity retention policy, compensation recovery policy, stock ownership guidelines and/or other similar
policies maintained by the Company, each as in effect from time to time and to the extent applicable to Participant from time to time. In addition, the Participant shall be subject to such compensation recovery, recoupment, forfeiture, or other
similar provisions as may apply at any time to the Participant under Applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>scsc-20241210.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 12/11/2024 2:59:02 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:scsc="http://www.scansource.com/20241210"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.scansource.com/20241210"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="scsc-20241210_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="scsc-20241210_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>scsc-20241210_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 12/11/2024 2:59:02 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>scsc-20241210_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 12/11/2024 2:59:02 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="scsc-20241210.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45949596157536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000918965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 10,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ScanSource, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">SC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">00-26926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">57-0965380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6 Logue Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Greenville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">SC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">29615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(864)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">288-2432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SCSC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88!.R
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M4$L! A0#%     @ ((N*60=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  @BXI9%!R[A^X    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M"  @BXI9F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( ""+BEFO7_&E.@0  '@0   8
M      " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M"  @BXI9GZ ;\+$"  #B#   #0              @ %]#   >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( ""+BEF7BKL<P    !,"   +              "
M 5D/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ""+BED<.&7J/P$  #P"   /
M              "  4(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  @
MBXI9)!Z;HJT   #X 0  &@              @ &N$0  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  @BXI999!YDAD!  #/ P  $P
M            @ &3$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"  #=$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d900233d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d900233d8k.htm">d900233d8k.htm</File>
    <File>scsc-20241210.xsd</File>
    <File>scsc-20241210_lab.xml</File>
    <File>scsc-20241210_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d900233d8k.htm": {
   "nsprefix": "scsc",
   "nsuri": "http://www.scansource.com/20241210",
   "dts": {
    "inline": {
     "local": [
      "d900233d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "scsc-20241210.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "scsc-20241210_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "scsc-20241210_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-12-10_to_2024-12-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d900233d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-12-10_to_2024-12-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d900233d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.scansource.com//20241210/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-274434-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-274434-xbrl.zip
M4$L#!!0    ( ""+BEF6S2?P)!@   +*   .    9#DP,#(S,V0X:RYH=&WM
M76ESXS;2_NY?@5(JB5U%':1NV:,MC^R9.)FQ_5K.;NK]DH)(R,*:(KD@95O[
MZ[<; "GJLFY?HZE*+(DX&HT^GFX<//G'4]\E#TR$W/<^_6KF"K\2YMF^P[V[
M3[^>MEL7%[_^HWEPTHN@&!3UPH;#^*=,+XJ"1C[_U!%N+F1V[LY_R,.#O%6P
M2AE=<!!FHV' PJ1TEX:=G"_N\O&3L>*>[WF#?E+X\?$Q)YO'"DXD\E@C#X6R
M4(H);L?UGESNW8]5>RS*2F:]7L_+IW'1J9))!U:A4,SCXPX-65P\M$-[K'AH
M4R_T!\)F.=OO2^I-RRPDE(1\%AW0MIG_Z_NWMMUC?9KE7AA1STYZ&41B+DWU
M/#R-"_+0+UEF]9D!Z!))A:=Y94THZ\%PV5^?;[Z-BD>SRX^*YB,!'.CZHD\C
M$!ALJ9PM6%FKDFHD"P(QSC8M((O:J66+9L)+Z)P_-]0)+N)39T(P=>%*7CW4
M1>>+"@IY!H6=40?^1#QR6;.6_>,DKSX>G/191 E6S[+_#/C#ITS+]R+F1=E;
M$,X,L=6W3YF(/45YV5P>:N55@X20DX[O#)LG#G\@831TV:>,P\/ I4.4?I9I
MDA/^U,#23.C/W'&8ISY#D4LE^L2C?:S+>..TSSP'_HN^N/1.4_ 4W; N/!X(
MR=V_44ZSII4U"W]'?NI;AG#G4X8_/63+M7*FV:5NR$[R8SU-]8PU?I-$_0W=
M_WWN 6N&+>A?4/?"<]C3'VR82=$WI\!J=#8+\*]NUNJ5\C1]^0DV"=9E FP8
M"^$[JC3H,2H>]+5+BR%[0AOU*1/R?N FO_4$#A)M238V&+FGT(D?4V$+'R5A
M<2=Y/=JQ$<KORBCA5ZDW#<U>.5M+L#>NQN1D)5^Y@S]T.1-$LI#-U.K6Q1_C
M$S19&:F>V7X ,^@[R5=0:!&=T8@U1[3%-4?/1K0Z<\K&3Y)NDW[R8]Q)N#GB
M7CZM?GE04_B34E:LE:4NO_,:-HR%B<SX\T?N1+U&+5?FWG&JK,NZT7&?BCON
M9?%S@]!!Y,>_"'[7TS]A<T'<&-K*;(_)I^"7@Z2)R \:J:\=/XK\OOREXPL@
M/?[%#)Y(Z+O<(3\5Y+],\Y>?S$KA^"0?S.NHN+@C:^V.4LW6H!$R/0#2A:G)
MAOR_K&'6DN]=VN?NL''+^RPDE^R1W/A]ZAW+9X^*[H[O.L<SIN?/RXO;\S/2
MOCV]/6_/)Z?P0N2TSUM_WES<7IRWR>GE&3G_J_7;Z>77<]*Z^O[]HMV^N+K<
MB$9K&S3^BX8]0'^1[QGD+-?*$:M0+M4GZ!IU6EM",,?E89%"S13,REJ"F2M
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M!8ISJ,1$/WQI%@-VZN-Q4J18CA7%0>ZK 58 V5/;:^2];+*0&CS (\4C%C:
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MUE#P6OA@NJ$1=<"#E.0#TY31N)K"6;'JLM&@1IEH7C"O$BZSVR1;G,RD3ZJ
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MMNPCXR@.F^T\V_$H767PV,+<=S()XXLPL3Z.Y&8=@W98MO+H*)Y&KS_ =0M
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M_L#9Q$PR1JO%)UMA8+/%;^:)[/@T-ZTEN+CA8V>8A$43PZ:3Z\ IQL'C2X=
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M'M(;&P]#3]+0]"1N/E9J*@_MP%W7NRI#>OZ35KCQP#C)K79+'24WTE=OPLG
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M+]Q0@F823%ZN#/U?:;SUP;=XZQ66UK4L*RG#)-3;OK6?1:,K=P"6'BDPQX:
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M<8\)?CATCU6C9"$QQ27'=3FPAS,1#P(_8>;5[AL!?1E\ZJ7_5 R?K^@^5[9
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MV/G56^P+^SW')#$">%9._I)F9:8Q+%90D3TO]MH7X&M@?-='H<(4*%TS+BA
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M6<7,<\X:T*[L5S3MC?7 )CK>NU(# TO1CPQLJ0WBYXU'5F1NJ!6N6OXO4BG
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M6@IHWC18;"*$[&78=S2HN/1  %N9K X.?V8 AQ.6;L*'<+KS2Y:K*TJ7/CN
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MCK0RP74[K4NAYQ"FVT)MV_%H2HBER&[F!RA"G?;O6F75V8VJJB4XN+ENVJ*
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M,>\K.B>W]/NAJ9_;)^IFN;:2>[HLC@IR/WR;7-;\.@6[X1>4&[YQO[7V?6&
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M4BP$QI<;H\1S4S=L%[+B"5^<W"FS2[$-XN+Y/L:EVT\,(I09Q#(27A>\3;\
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M"M7S.+A=BQ2*E#:$GL%V!Z\9&B[^8_Z[_U1^?YYCBFC5M_002FD'O=MT*05
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M;0XDB%'[*08@_.=+=7@&WYZ?'9]>G9Z?77Z3],C!]J;R& #\G(>IFZ&G)>
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M"2O<"+D&+Y*9$<N7ZELR+KC'E(Y!*8\AKH?W KL@"D]DCD=]R1HTDKCEL@S
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M_2;P^E-MT[HP74A3X2FTY9#?(8EL%XN_4/WO!>J]X O<&N%ABT<^#+:P53B
M=\WD*2?Y#<<07K@HY:]7 4,.=#!D,:Z  '962OK]M.(M9D8E">FR'P^$!@]
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M+@*NOHIZ*!W:'/'1U0S[5 +R(HX)U76-<0J>;.#/[>@Q:@HRK+MX?,_.7:#
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M]?W@>G\+_]<I^)+^LZK_ U!+ P04    "  @BXI9Z:-^OSP#  !3"P  $0
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M#F#5L2/;#/#O>QQP12#,PG1;Q5SPX?@]?L]YC$E,KCXL,TY>0&DF12>(&\V
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M\-SH5$@[XOK3VC'LL/WH#;;UVC" *;.)"O-(LZ.I56OK"ZW:KV/VDV?,\+)
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M,C,S9#AK+FAT;5!+ 0(4 Q0    ( ""+BEDHN4QE3XD  "J_ @ 1
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H8RTR,#(T,3(Q,%]P<F4N>&UL4$L%!@     &  8 ?P$  /',      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d900233d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="scsc-20241210.xsd" xlink:type="simple"/>
    <context id="duration_2024-12-10_to_2024-12-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000918965</identifier>
        </entity>
        <period>
            <startDate>2024-12-10</startDate>
            <endDate>2024-12-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-585">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-12-10_to_2024-12-10"
      id="Hidden_dei_EntityCentralIndexKey">0000918965</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-596">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-597">2024-12-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-598">ScanSource, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-599">SC</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-600">00-26926</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-601">57-0965380</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-602">6 Logue Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-603">Greenville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-604">SC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-605">29615</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-606">(864)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-607">288-2432</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-608">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-609">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-610">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-611">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-612">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-613">SCSC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-614">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-12-10_to_2024-12-10" id="ixv-615">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
